averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MAZ
|
ENSG00000103495.9 | MYC associated zinc finger protein |
ZNF281
|
ENSG00000162702.7 | zinc finger protein 281 |
GTF2F1
|
ENSG00000125651.9 | general transcription factor IIF subunit 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GTF2F1 | hg19_v2_chr19_-_6393465_6393479 | -0.46 | 1.0e-12 | Click! |
MAZ | hg19_v2_chr16_+_29818857_29819023 | -0.41 | 1.9e-10 | Click! |
ZNF281 | hg19_v2_chr1_-_200379180_200379191, hg19_v2_chr1_-_200379129_200379174, hg19_v2_chr1_-_200379104_200379128 | -0.20 | 3.2e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_20812690 | 84.93 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr8_+_80523962 | 78.37 |
ENST00000518491.1
|
STMN2
|
stathmin-like 2 |
chr6_-_29600832 | 76.66 |
ENST00000377016.4
ENST00000376977.3 ENST00000377034.4 |
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr11_-_64410787 | 71.08 |
ENST00000301894.2
|
NRXN2
|
neurexin 2 |
chr11_-_111783595 | 65.20 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
chr19_-_49149553 | 59.16 |
ENST00000084798.4
|
CA11
|
carbonic anhydrase XI |
chr11_-_111782696 | 53.23 |
ENST00000227251.3
ENST00000526180.1 |
CRYAB
|
crystallin, alpha B |
chr12_-_6798616 | 51.70 |
ENST00000355772.4
ENST00000417772.3 ENST00000396801.3 ENST00000396799.2 |
ZNF384
|
zinc finger protein 384 |
chr9_-_122131696 | 50.14 |
ENST00000373964.2
ENST00000265922.3 |
BRINP1
|
bone morphogenetic protein/retinoic acid inducible neural-specific 1 |
chr11_-_64490634 | 48.87 |
ENST00000377559.3
ENST00000265459.6 |
NRXN2
|
neurexin 2 |
chr12_-_6798523 | 48.43 |
ENST00000319770.3
|
ZNF384
|
zinc finger protein 384 |
chr12_-_6798410 | 47.20 |
ENST00000361959.3
ENST00000436774.2 ENST00000544482.1 |
ZNF384
|
zinc finger protein 384 |
chr1_+_160085501 | 46.80 |
ENST00000361216.3
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chrX_-_102319092 | 46.80 |
ENST00000372728.3
|
BEX1
|
brain expressed, X-linked 1 |
chr11_-_111784005 | 46.74 |
ENST00000527899.1
|
CRYAB
|
crystallin, alpha B |
chr2_+_79740118 | 45.90 |
ENST00000496558.1
ENST00000451966.1 |
CTNNA2
|
catenin (cadherin-associated protein), alpha 2 |
chr17_+_77681075 | 45.80 |
ENST00000397549.2
|
CTD-2116F7.1
|
CTD-2116F7.1 |
chr12_+_7023735 | 45.78 |
ENST00000538763.1
ENST00000544774.1 ENST00000545045.2 |
ENO2
|
enolase 2 (gamma, neuronal) |
chrX_+_101380642 | 44.84 |
ENST00000372780.1
ENST00000329035.2 |
TCEAL2
|
transcription elongation factor A (SII)-like 2 |
chr17_+_42385927 | 44.80 |
ENST00000426726.3
ENST00000590941.1 ENST00000225441.7 |
RUNDC3A
|
RUN domain containing 3A |
chr12_+_53773944 | 44.23 |
ENST00000551969.1
ENST00000327443.4 |
SP1
|
Sp1 transcription factor |
chr19_+_56652686 | 43.25 |
ENST00000592949.1
|
ZNF444
|
zinc finger protein 444 |
chr20_+_34742650 | 43.02 |
ENST00000373945.1
ENST00000338074.2 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chr1_+_65775204 | 42.85 |
ENST00000371069.4
|
DNAJC6
|
DnaJ (Hsp40) homolog, subfamily C, member 6 |
chr22_-_27620603 | 42.84 |
ENST00000418271.1
ENST00000444114.1 |
RP5-1172A22.1
|
RP5-1172A22.1 |
chrX_+_23352133 | 42.08 |
ENST00000379361.4
|
PTCHD1
|
patched domain containing 1 |
chr3_-_10547333 | 41.08 |
ENST00000383800.4
|
ATP2B2
|
ATPase, Ca++ transporting, plasma membrane 2 |
chr11_-_111783919 | 41.03 |
ENST00000531198.1
ENST00000533879.1 |
CRYAB
|
crystallin, alpha B |
chr3_+_11034403 | 41.02 |
ENST00000287766.4
ENST00000425938.1 |
SLC6A1
|
solute carrier family 6 (neurotransmitter transporter), member 1 |
chr20_+_10199468 | 40.43 |
ENST00000254976.2
ENST00000304886.2 |
SNAP25
|
synaptosomal-associated protein, 25kDa |
chr11_-_111782484 | 39.75 |
ENST00000533971.1
|
CRYAB
|
crystallin, alpha B |
chr12_+_6930813 | 39.70 |
ENST00000428545.2
|
GPR162
|
G protein-coupled receptor 162 |
chr7_+_121513143 | 38.66 |
ENST00000393386.2
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
chr3_-_133614597 | 37.99 |
ENST00000285208.4
ENST00000460865.3 |
RAB6B
|
RAB6B, member RAS oncogene family |
chr2_+_17721920 | 37.91 |
ENST00000295156.4
|
VSNL1
|
visinin-like 1 |
chr3_-_133614421 | 37.88 |
ENST00000543906.1
|
RAB6B
|
RAB6B, member RAS oncogene family |
chrX_+_103031758 | 37.66 |
ENST00000303958.2
ENST00000361621.2 |
PLP1
|
proteolipid protein 1 |
chr14_-_81687197 | 37.57 |
ENST00000553612.1
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr15_-_88799661 | 37.36 |
ENST00000360948.2
ENST00000357724.2 ENST00000355254.2 ENST00000317501.3 |
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3 |
chr14_-_27066960 | 37.19 |
ENST00000539517.2
|
NOVA1
|
neuro-oncological ventral antigen 1 |
chr3_-_10547192 | 36.85 |
ENST00000360273.2
ENST00000343816.4 |
ATP2B2
|
ATPase, Ca++ transporting, plasma membrane 2 |
chr14_-_21490590 | 36.77 |
ENST00000557633.1
|
NDRG2
|
NDRG family member 2 |
chr2_-_220173685 | 36.74 |
ENST00000423636.2
ENST00000442029.1 ENST00000412847.1 |
PTPRN
|
protein tyrosine phosphatase, receptor type, N |
chr19_-_36523709 | 36.69 |
ENST00000592017.1
ENST00000360535.4 |
CLIP3
|
CAP-GLY domain containing linker protein 3 |
chr19_+_35521616 | 36.68 |
ENST00000595652.1
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr14_+_29236269 | 36.28 |
ENST00000313071.4
|
FOXG1
|
forkhead box G1 |
chr12_+_6930964 | 35.77 |
ENST00000382315.3
|
GPR162
|
G protein-coupled receptor 162 |
chr16_+_56623433 | 35.57 |
ENST00000570176.1
|
MT3
|
metallothionein 3 |
chr3_+_115342349 | 35.54 |
ENST00000393780.3
|
GAP43
|
growth associated protein 43 |
chr19_-_47975417 | 35.51 |
ENST00000236877.6
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
chr5_-_88179302 | 35.22 |
ENST00000504921.2
|
MEF2C
|
myocyte enhancer factor 2C |
chr8_+_24771265 | 35.04 |
ENST00000518131.1
ENST00000437366.2 |
NEFM
|
neurofilament, medium polypeptide |
chr3_+_115342159 | 34.29 |
ENST00000305124.6
|
GAP43
|
growth associated protein 43 |
chr1_-_204380919 | 34.24 |
ENST00000367188.4
|
PPP1R15B
|
protein phosphatase 1, regulatory subunit 15B |
chr14_-_21493123 | 34.24 |
ENST00000556147.1
ENST00000554489.1 ENST00000555657.1 ENST00000557274.1 ENST00000555158.1 ENST00000554833.1 ENST00000555384.1 ENST00000556420.1 ENST00000554893.1 ENST00000553503.1 ENST00000555733.1 ENST00000553867.1 ENST00000397856.3 ENST00000397855.3 ENST00000556008.1 ENST00000557182.1 ENST00000554483.1 ENST00000556688.1 ENST00000397853.3 ENST00000556329.2 ENST00000554143.1 ENST00000397851.2 ENST00000555142.1 ENST00000557676.1 ENST00000556924.1 |
NDRG2
|
NDRG family member 2 |
chr17_-_26903900 | 34.23 |
ENST00000395319.3
ENST00000581807.1 ENST00000584086.1 ENST00000395321.2 |
ALDOC
|
aldolase C, fructose-bisphosphate |
chr12_-_54982300 | 34.08 |
ENST00000547431.1
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
chr4_-_16900410 | 33.31 |
ENST00000304523.5
|
LDB2
|
LIM domain binding 2 |
chr8_+_1922024 | 33.30 |
ENST00000320248.3
|
KBTBD11
|
kelch repeat and BTB (POZ) domain containing 11 |
chr20_+_44657845 | 33.27 |
ENST00000243964.3
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
chr7_-_143059780 | 32.51 |
ENST00000409578.1
ENST00000409346.1 |
FAM131B
|
family with sequence similarity 131, member B |
chr13_+_88324870 | 32.47 |
ENST00000325089.6
|
SLITRK5
|
SLIT and NTRK-like family, member 5 |
chr6_+_17393888 | 32.33 |
ENST00000493172.1
ENST00000465994.1 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr17_+_29718642 | 32.07 |
ENST00000325874.8
|
RAB11FIP4
|
RAB11 family interacting protein 4 (class II) |
chr6_+_17393839 | 32.04 |
ENST00000489374.1
ENST00000378990.2 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr15_-_88799948 | 31.69 |
ENST00000394480.2
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3 |
chr5_+_148786423 | 31.31 |
ENST00000505254.2
ENST00000602964.1 ENST00000519898.1 |
MIR143HG
|
MIR143 host gene (non-protein coding) |
chr1_-_154193009 | 31.15 |
ENST00000368518.1
ENST00000368519.1 ENST00000368521.5 |
C1orf43
|
chromosome 1 open reading frame 43 |
chr7_+_153749732 | 31.08 |
ENST00000377770.3
|
DPP6
|
dipeptidyl-peptidase 6 |
chr14_-_21493884 | 31.07 |
ENST00000556974.1
ENST00000554419.1 ENST00000298687.5 ENST00000397858.1 ENST00000360463.3 ENST00000350792.3 ENST00000397847.2 |
NDRG2
|
NDRG family member 2 |
chr16_-_21289627 | 30.98 |
ENST00000396023.2
ENST00000415987.2 |
CRYM
|
crystallin, mu |
chr4_-_5890145 | 30.71 |
ENST00000397890.2
|
CRMP1
|
collapsin response mediator protein 1 |
chr4_-_90758118 | 30.47 |
ENST00000420646.2
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chrX_+_102631844 | 30.43 |
ENST00000372634.1
ENST00000299872.7 |
NGFRAP1
|
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr19_+_56652556 | 30.35 |
ENST00000337080.3
|
ZNF444
|
zinc finger protein 444 |
chrX_-_49056635 | 30.33 |
ENST00000472598.1
ENST00000538567.1 ENST00000479808.1 ENST00000263233.4 |
SYP
|
synaptophysin |
chr12_+_6930703 | 30.17 |
ENST00000311268.3
|
GPR162
|
G protein-coupled receptor 162 |
chr14_-_21493649 | 30.16 |
ENST00000553442.1
ENST00000555869.1 ENST00000556457.1 ENST00000397844.2 ENST00000554415.1 |
NDRG2
|
NDRG family member 2 |
chr14_-_81687575 | 30.14 |
ENST00000434192.2
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr16_+_56225248 | 30.02 |
ENST00000262493.6
|
GNAO1
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
chr12_-_45270151 | 29.83 |
ENST00000429094.2
|
NELL2
|
NEL-like 2 (chicken) |
chr12_-_45270077 | 29.45 |
ENST00000551601.1
ENST00000549027.1 ENST00000452445.2 |
NELL2
|
NEL-like 2 (chicken) |
chr20_-_3154162 | 29.16 |
ENST00000360342.3
|
LZTS3
|
Homo sapiens leucine zipper, putative tumor suppressor family member 3 (LZTS3), mRNA. |
chrX_+_103031421 | 29.10 |
ENST00000433491.1
ENST00000418604.1 ENST00000443502.1 |
PLP1
|
proteolipid protein 1 |
chr11_-_134281812 | 29.08 |
ENST00000392580.1
ENST00000312527.4 |
B3GAT1
|
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
chr4_-_16900242 | 28.93 |
ENST00000502640.1
ENST00000506732.1 |
LDB2
|
LIM domain binding 2 |
chr8_-_22089533 | 28.82 |
ENST00000321613.3
|
PHYHIP
|
phytanoyl-CoA 2-hydroxylase interacting protein |
chr1_-_156217875 | 28.73 |
ENST00000292291.5
|
PAQR6
|
progestin and adipoQ receptor family member VI |
chr16_+_85061367 | 28.71 |
ENST00000538274.1
ENST00000258180.3 |
KIAA0513
|
KIAA0513 |
chr1_-_156217829 | 28.65 |
ENST00000356983.2
ENST00000335852.1 ENST00000340183.5 ENST00000540423.1 |
PAQR6
|
progestin and adipoQ receptor family member VI |
chr16_+_29911864 | 28.62 |
ENST00000308748.5
|
ASPHD1
|
aspartate beta-hydroxylase domain containing 1 |
chr19_-_6502304 | 28.52 |
ENST00000540257.1
ENST00000594276.1 ENST00000594075.1 ENST00000600216.1 ENST00000596926.1 |
TUBB4A
|
tubulin, beta 4A class IVa |
chr16_+_2039946 | 28.50 |
ENST00000248121.2
ENST00000568896.1 |
SYNGR3
|
synaptogyrin 3 |
chr5_+_17217669 | 28.33 |
ENST00000322611.3
|
BASP1
|
brain abundant, membrane attached signal protein 1 |
chr17_-_79139817 | 28.13 |
ENST00000326724.4
|
AATK
|
apoptosis-associated tyrosine kinase |
chr14_-_60337684 | 27.96 |
ENST00000267484.5
|
RTN1
|
reticulon 1 |
chr9_-_111929560 | 27.53 |
ENST00000561981.2
|
FRRS1L
|
ferric-chelate reductase 1-like |
chr12_+_66218212 | 27.46 |
ENST00000393578.3
ENST00000425208.2 ENST00000536545.1 ENST00000354636.3 |
HMGA2
|
high mobility group AT-hook 2 |
chr5_+_140345820 | 27.41 |
ENST00000289269.5
|
PCDHAC2
|
protocadherin alpha subfamily C, 2 |
chr14_-_23822080 | 27.16 |
ENST00000397267.1
ENST00000354772.3 |
SLC22A17
|
solute carrier family 22, member 17 |
chr20_+_57466629 | 26.97 |
ENST00000371081.1
ENST00000338783.6 |
GNAS
|
GNAS complex locus |
chr12_+_113229737 | 26.92 |
ENST00000551052.1
ENST00000415485.3 |
RPH3A
|
rabphilin 3A homolog (mouse) |
chr20_-_524362 | 26.69 |
ENST00000460062.2
ENST00000608066.1 |
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide |
chr4_-_90758227 | 26.66 |
ENST00000506691.1
ENST00000394986.1 ENST00000506244.1 ENST00000394989.2 ENST00000394991.3 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr6_-_6007200 | 26.65 |
ENST00000244766.2
|
NRN1
|
neuritin 1 |
chr2_+_149632783 | 26.37 |
ENST00000435030.1
|
KIF5C
|
kinesin family member 5C |
chr15_+_74422585 | 26.07 |
ENST00000561740.1
ENST00000435464.1 ENST00000453268.2 |
ISLR2
|
immunoglobulin superfamily containing leucine-rich repeat 2 |
chr8_+_21912328 | 26.01 |
ENST00000432128.1
ENST00000443491.2 ENST00000517600.1 ENST00000523782.2 |
DMTN
|
dematin actin binding protein |
chr1_+_204797749 | 25.88 |
ENST00000367172.4
ENST00000367171.4 ENST00000367170.4 ENST00000338515.6 ENST00000339876.6 ENST00000338586.6 ENST00000539706.1 ENST00000360049.4 ENST00000367169.4 ENST00000446412.1 ENST00000403080.1 |
NFASC
|
neurofascin |
chr1_+_183441500 | 25.88 |
ENST00000456731.2
|
SMG7
|
SMG7 nonsense mediated mRNA decay factor |
chr4_+_158141806 | 25.83 |
ENST00000393815.2
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
chr12_-_53614155 | 25.78 |
ENST00000543726.1
|
RARG
|
retinoic acid receptor, gamma |
chr1_-_149889382 | 25.64 |
ENST00000369145.1
ENST00000369146.3 |
SV2A
|
synaptic vesicle glycoprotein 2A |
chr4_-_16900184 | 25.57 |
ENST00000515064.1
|
LDB2
|
LIM domain binding 2 |
chr19_-_3028354 | 25.28 |
ENST00000586422.1
|
TLE2
|
transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) |
chr13_-_67804445 | 25.05 |
ENST00000456367.1
ENST00000377861.3 ENST00000544246.1 |
PCDH9
|
protocadherin 9 |
chr12_-_16758304 | 25.02 |
ENST00000320122.6
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr1_-_177133818 | 25.01 |
ENST00000424564.2
ENST00000361833.2 |
ASTN1
|
astrotactin 1 |
chr4_+_158141843 | 24.91 |
ENST00000509417.1
ENST00000296526.7 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
chr11_-_117747607 | 24.86 |
ENST00000540359.1
ENST00000539526.1 |
FXYD6
|
FXYD domain containing ion transport regulator 6 |
chr14_-_23822061 | 24.75 |
ENST00000397260.3
|
SLC22A17
|
solute carrier family 22, member 17 |
chr16_-_49890016 | 24.46 |
ENST00000563137.2
|
ZNF423
|
zinc finger protein 423 |
chr19_-_13617037 | 24.33 |
ENST00000360228.5
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
chr12_-_53614043 | 24.32 |
ENST00000338561.5
|
RARG
|
retinoic acid receptor, gamma |
chr12_+_57522258 | 24.31 |
ENST00000553277.1
ENST00000243077.3 |
LRP1
|
low density lipoprotein receptor-related protein 1 |
chr15_+_68871569 | 24.27 |
ENST00000566799.1
|
CORO2B
|
coronin, actin binding protein, 2B |
chr4_+_158141899 | 24.24 |
ENST00000264426.9
ENST00000506284.1 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
chr12_+_110718921 | 23.83 |
ENST00000308664.6
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
chrX_-_137793826 | 23.75 |
ENST00000315930.6
|
FGF13
|
fibroblast growth factor 13 |
chr1_-_241520525 | 23.63 |
ENST00000366565.1
|
RGS7
|
regulator of G-protein signaling 7 |
chr22_-_38380543 | 23.60 |
ENST00000396884.2
|
SOX10
|
SRY (sex determining region Y)-box 10 |
chr20_-_4804244 | 23.56 |
ENST00000379400.3
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2 |
chr17_-_27278304 | 23.50 |
ENST00000577226.1
|
PHF12
|
PHD finger protein 12 |
chr7_-_105029329 | 23.31 |
ENST00000393651.3
ENST00000460391.1 |
SRPK2
|
SRSF protein kinase 2 |
chr16_+_69166418 | 23.20 |
ENST00000314423.7
ENST00000562237.1 ENST00000567460.1 ENST00000566227.1 ENST00000352319.4 ENST00000563094.1 |
CIRH1A
|
cirrhosis, autosomal recessive 1A (cirhin) |
chr6_-_110500905 | 23.19 |
ENST00000392587.2
|
WASF1
|
WAS protein family, member 1 |
chr6_+_121756809 | 23.19 |
ENST00000282561.3
|
GJA1
|
gap junction protein, alpha 1, 43kDa |
chr4_-_16900217 | 23.07 |
ENST00000441778.2
|
LDB2
|
LIM domain binding 2 |
chr11_-_117747434 | 23.00 |
ENST00000529335.2
ENST00000530956.1 ENST00000260282.4 |
FXYD6
|
FXYD domain containing ion transport regulator 6 |
chr4_+_190992087 | 22.98 |
ENST00000553598.1
|
DUX4L7
|
double homeobox 4 like 7 |
chrX_-_13956497 | 22.78 |
ENST00000398361.3
|
GPM6B
|
glycoprotein M6B |
chr7_-_143059845 | 22.66 |
ENST00000443739.2
|
FAM131B
|
family with sequence similarity 131, member B |
chr15_+_78730622 | 22.63 |
ENST00000560440.1
|
IREB2
|
iron-responsive element binding protein 2 |
chr8_-_103136481 | 22.61 |
ENST00000524209.1
ENST00000517822.1 ENST00000523923.1 ENST00000521599.1 ENST00000521964.1 ENST00000311028.3 ENST00000518166.1 |
NCALD
|
neurocalcin delta |
chr2_-_37193606 | 22.48 |
ENST00000379213.2
ENST00000263918.4 |
STRN
|
striatin, calmodulin binding protein |
chr19_+_45754505 | 22.43 |
ENST00000262891.4
ENST00000300843.4 |
MARK4
|
MAP/microtubule affinity-regulating kinase 4 |
chr5_-_131132614 | 22.41 |
ENST00000307968.7
ENST00000307954.8 |
FNIP1
|
folliculin interacting protein 1 |
chr19_+_708910 | 22.32 |
ENST00000264560.7
|
PALM
|
paralemmin |
chr7_+_86273700 | 22.28 |
ENST00000546348.1
|
GRM3
|
glutamate receptor, metabotropic 3 |
chr8_-_22089845 | 22.10 |
ENST00000454243.2
|
PHYHIP
|
phytanoyl-CoA 2-hydroxylase interacting protein |
chr19_-_42498369 | 22.05 |
ENST00000302102.5
ENST00000545399.1 |
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
chr2_-_73511559 | 22.01 |
ENST00000521871.1
|
FBXO41
|
F-box protein 41 |
chr19_+_35521572 | 21.98 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr12_-_54982420 | 21.93 |
ENST00000257905.8
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
chr17_-_42277203 | 21.85 |
ENST00000587097.1
|
ATXN7L3
|
ataxin 7-like 3 |
chr7_-_79082867 | 21.84 |
ENST00000419488.1
ENST00000354212.4 |
MAGI2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
chr17_-_47755338 | 21.77 |
ENST00000508805.1
ENST00000515508.2 ENST00000451526.2 ENST00000507970.1 |
SPOP
|
speckle-type POZ protein |
chr15_+_75118888 | 21.75 |
ENST00000395018.4
|
CPLX3
|
complexin 3 |
chr15_-_75743991 | 21.62 |
ENST00000567289.1
|
SIN3A
|
SIN3 transcription regulator family member A |
chr8_-_144241664 | 21.47 |
ENST00000342752.4
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
chr1_-_183387723 | 21.47 |
ENST00000287713.6
|
NMNAT2
|
nicotinamide nucleotide adenylyltransferase 2 |
chr9_+_130374537 | 21.45 |
ENST00000373302.3
ENST00000373299.1 |
STXBP1
|
syntaxin binding protein 1 |
chrX_-_47479246 | 21.42 |
ENST00000295987.7
ENST00000340666.4 |
SYN1
|
synapsin I |
chr19_-_42498231 | 21.37 |
ENST00000602133.1
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
chr15_+_84116106 | 21.32 |
ENST00000535412.1
ENST00000324537.5 |
SH3GL3
|
SH3-domain GRB2-like 3 |
chr19_+_18723660 | 21.24 |
ENST00000262817.3
|
TMEM59L
|
transmembrane protein 59-like |
chr11_-_132813566 | 21.14 |
ENST00000331898.7
|
OPCML
|
opioid binding protein/cell adhesion molecule-like |
chr6_+_107811162 | 21.06 |
ENST00000317357.5
|
SOBP
|
sine oculis binding protein homolog (Drosophila) |
chr14_-_51562745 | 21.05 |
ENST00000298355.3
|
TRIM9
|
tripartite motif containing 9 |
chrX_-_54384425 | 20.99 |
ENST00000375169.3
ENST00000354646.2 |
WNK3
|
WNK lysine deficient protein kinase 3 |
chr20_-_23618582 | 20.96 |
ENST00000398411.1
ENST00000376925.3 |
CST3
|
cystatin C |
chr19_-_18314836 | 20.87 |
ENST00000464076.3
ENST00000222256.4 |
RAB3A
|
RAB3A, member RAS oncogene family |
chr7_-_105029812 | 20.82 |
ENST00000482897.1
|
SRPK2
|
SRSF protein kinase 2 |
chr11_-_72385437 | 20.71 |
ENST00000418754.2
ENST00000542969.2 ENST00000334456.5 |
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated |
chr1_-_182361327 | 20.70 |
ENST00000331872.6
ENST00000311223.5 |
GLUL
|
glutamate-ammonia ligase |
chrX_+_110339439 | 20.70 |
ENST00000372010.1
ENST00000519681.1 ENST00000372007.5 |
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3 |
chrX_-_51239425 | 20.64 |
ENST00000375992.3
|
NUDT11
|
nudix (nucleoside diphosphate linked moiety X)-type motif 11 |
chr4_-_46391805 | 20.54 |
ENST00000540012.1
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
chr13_+_35516390 | 20.53 |
ENST00000540320.1
ENST00000400445.3 ENST00000310336.4 |
NBEA
|
neurobeachin |
chr14_-_21492113 | 20.47 |
ENST00000554094.1
|
NDRG2
|
NDRG family member 2 |
chr12_-_53574671 | 20.28 |
ENST00000444623.1
|
CSAD
|
cysteine sulfinic acid decarboxylase |
chr16_-_28481868 | 20.24 |
ENST00000452313.1
|
NPIPB7
|
nuclear pore complex interacting protein family, member B7 |
chr7_-_158380371 | 20.23 |
ENST00000389418.4
ENST00000389416.4 |
PTPRN2
|
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
chr20_-_62103862 | 20.17 |
ENST00000344462.4
ENST00000357249.2 ENST00000359125.2 ENST00000360480.3 ENST00000370224.1 ENST00000344425.5 ENST00000354587.3 ENST00000359689.1 |
KCNQ2
|
potassium voltage-gated channel, KQT-like subfamily, member 2 |
chr7_-_766879 | 20.13 |
ENST00000537384.1
ENST00000417852.1 |
PRKAR1B
|
protein kinase, cAMP-dependent, regulatory, type I, beta |
chr7_+_86273952 | 20.12 |
ENST00000536043.1
|
GRM3
|
glutamate receptor, metabotropic 3 |
chr11_-_2906979 | 20.10 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
chr14_-_23834411 | 20.07 |
ENST00000429593.2
|
EFS
|
embryonal Fyn-associated substrate |
chr20_+_5892037 | 20.05 |
ENST00000378961.4
|
CHGB
|
chromogranin B (secretogranin 1) |
chr19_+_49622646 | 20.00 |
ENST00000334186.4
|
PPFIA3
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
chr17_-_42992856 | 19.96 |
ENST00000588316.1
ENST00000435360.2 ENST00000586793.1 ENST00000588735.1 ENST00000588037.1 ENST00000592320.1 ENST00000253408.5 |
GFAP
|
glial fibrillary acidic protein |
chr16_+_226658 | 19.93 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
chr17_-_36956155 | 19.90 |
ENST00000269554.3
|
PIP4K2B
|
phosphatidylinositol-5-phosphate 4-kinase, type II, beta |
chr16_+_28834531 | 19.89 |
ENST00000570200.1
|
ATXN2L
|
ataxin 2-like |
chr4_-_153456153 | 19.84 |
ENST00000603548.1
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr19_+_12949251 | 19.82 |
ENST00000251472.4
|
MAST1
|
microtubule associated serine/threonine kinase 1 |
chr11_+_17756279 | 19.72 |
ENST00000265969.6
|
KCNC1
|
potassium voltage-gated channel, Shaw-related subfamily, member 1 |
chr22_+_51039098 | 19.60 |
ENST00000399912.1
ENST00000329492.3 ENST00000442429.2 ENST00000341339.4 |
MAPK8IP2
|
mitogen-activated protein kinase 8 interacting protein 2 |
chr1_-_150669604 | 19.44 |
ENST00000427665.1
ENST00000540514.1 |
GOLPH3L
|
golgi phosphoprotein 3-like |
chr19_-_42573650 | 19.32 |
ENST00000593562.1
|
GRIK5
|
glutamate receptor, ionotropic, kainate 5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
29.4 | 88.3 | GO:0048691 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
22.5 | 180.3 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
22.2 | 88.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
20.5 | 61.6 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
19.6 | 58.7 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
17.1 | 51.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
16.2 | 64.9 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
15.7 | 15.7 | GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) |
14.5 | 232.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
14.5 | 58.0 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
13.3 | 40.0 | GO:1990502 | dense core granule maturation(GO:1990502) |
13.3 | 239.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
12.7 | 38.1 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
12.5 | 124.7 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
12.1 | 36.3 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
12.1 | 36.2 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
12.0 | 60.0 | GO:0070384 | Harderian gland development(GO:0070384) |
11.6 | 23.2 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
11.4 | 45.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
11.2 | 44.8 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
11.1 | 44.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
11.0 | 33.1 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
10.9 | 21.8 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
10.4 | 51.8 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
10.4 | 20.7 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
10.2 | 61.5 | GO:0070560 | protein secretion by platelet(GO:0070560) |
10.2 | 40.8 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
10.2 | 30.6 | GO:0051595 | response to methylglyoxal(GO:0051595) |
10.2 | 20.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
10.0 | 30.1 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
10.0 | 60.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
9.9 | 29.8 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
9.8 | 29.4 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
9.6 | 28.8 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
9.4 | 46.8 | GO:0051946 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
9.3 | 27.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
9.1 | 100.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
9.1 | 18.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
9.1 | 45.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
8.5 | 25.6 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
8.5 | 42.5 | GO:2001076 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
8.4 | 33.7 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
8.3 | 24.9 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
8.1 | 24.3 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
8.1 | 48.5 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
8.1 | 24.2 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
8.0 | 8.0 | GO:0042742 | defense response to bacterium(GO:0042742) |
7.9 | 55.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
7.8 | 39.1 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
7.7 | 15.5 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
7.7 | 77.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
7.6 | 7.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
7.6 | 22.7 | GO:2000173 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
7.5 | 7.5 | GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
7.5 | 22.5 | GO:0035978 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
7.4 | 22.1 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
7.4 | 29.5 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
7.4 | 36.8 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
7.3 | 36.6 | GO:0003322 | pancreatic A cell development(GO:0003322) |
7.2 | 21.5 | GO:0061535 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) glutamate secretion, neurotransmission(GO:0061535) |
7.2 | 7.2 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
7.1 | 35.7 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
7.1 | 63.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
7.0 | 20.9 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
7.0 | 13.9 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
6.9 | 27.7 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
6.9 | 34.6 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
6.9 | 96.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
6.9 | 48.2 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
6.8 | 40.7 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
6.7 | 20.2 | GO:0021678 | fourth ventricle development(GO:0021592) third ventricle development(GO:0021678) |
6.6 | 33.0 | GO:1901911 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
6.5 | 19.5 | GO:0021780 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
6.5 | 45.4 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
6.3 | 50.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
6.3 | 18.8 | GO:0001207 | histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
6.3 | 25.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
6.3 | 56.4 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
6.3 | 18.8 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
6.3 | 18.8 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
6.2 | 43.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
6.2 | 12.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
6.2 | 30.8 | GO:0030070 | insulin processing(GO:0030070) |
6.1 | 24.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
6.0 | 48.3 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
5.9 | 117.4 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
5.8 | 11.7 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
5.8 | 251.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
5.8 | 29.0 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
5.8 | 86.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
5.8 | 5.8 | GO:1901725 | positive regulation of deacetylase activity(GO:0090045) regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
5.7 | 17.0 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
5.6 | 28.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
5.6 | 27.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
5.6 | 27.9 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
5.6 | 22.3 | GO:0048749 | compound eye development(GO:0048749) |
5.5 | 16.6 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
5.5 | 27.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
5.5 | 11.0 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
5.4 | 5.4 | GO:1903061 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
5.3 | 16.0 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
5.3 | 16.0 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
5.3 | 21.3 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
5.2 | 20.8 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
5.2 | 5.2 | GO:0021953 | central nervous system neuron differentiation(GO:0021953) |
5.1 | 20.5 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
5.1 | 20.4 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
5.0 | 20.1 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
5.0 | 20.1 | GO:1902612 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
5.0 | 5.0 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
4.9 | 14.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
4.9 | 43.9 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
4.8 | 14.3 | GO:0090427 | activation of meiosis(GO:0090427) |
4.8 | 14.3 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
4.7 | 4.7 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
4.7 | 14.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
4.7 | 18.8 | GO:0060023 | soft palate development(GO:0060023) |
4.7 | 37.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
4.7 | 18.7 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
4.7 | 14.0 | GO:0009447 | putrescine catabolic process(GO:0009447) |
4.7 | 9.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
4.7 | 32.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
4.7 | 18.6 | GO:0051541 | elastin metabolic process(GO:0051541) |
4.6 | 4.6 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
4.6 | 27.9 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
4.6 | 50.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
4.6 | 4.6 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
4.6 | 27.6 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
4.6 | 18.2 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
4.6 | 18.2 | GO:0019086 | late viral transcription(GO:0019086) |
4.5 | 31.8 | GO:1902527 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) positive regulation of protein monoubiquitination(GO:1902527) |
4.5 | 4.5 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
4.4 | 22.2 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
4.4 | 8.9 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
4.4 | 48.6 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
4.4 | 13.3 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
4.4 | 26.5 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
4.3 | 4.3 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
4.3 | 13.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
4.3 | 21.5 | GO:1904141 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
4.3 | 21.3 | GO:0070842 | aggresome assembly(GO:0070842) |
4.2 | 42.2 | GO:0034465 | response to carbon monoxide(GO:0034465) |
4.2 | 4.2 | GO:0048536 | spleen development(GO:0048536) |
4.2 | 25.0 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
4.2 | 8.3 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
4.1 | 33.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
4.0 | 72.1 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
4.0 | 11.9 | GO:0061743 | motor learning(GO:0061743) |
4.0 | 111.3 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
4.0 | 47.5 | GO:0060004 | reflex(GO:0060004) |
3.9 | 19.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
3.9 | 15.7 | GO:0007418 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
3.9 | 15.6 | GO:2000537 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
3.9 | 31.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
3.8 | 15.4 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
3.8 | 19.2 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
3.8 | 46.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
3.8 | 11.4 | GO:1904647 | response to rotenone(GO:1904647) |
3.8 | 15.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
3.7 | 22.4 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
3.7 | 7.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
3.7 | 26.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
3.7 | 44.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
3.7 | 7.4 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
3.7 | 11.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
3.7 | 3.7 | GO:0043153 | photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
3.7 | 7.3 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
3.6 | 3.6 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
3.6 | 3.6 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
3.6 | 127.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
3.6 | 54.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
3.6 | 14.4 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
3.6 | 43.0 | GO:0021794 | thalamus development(GO:0021794) |
3.6 | 21.4 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
3.6 | 3.6 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
3.6 | 3.6 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
3.5 | 3.5 | GO:0033344 | cholesterol efflux(GO:0033344) |
3.5 | 14.1 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
3.5 | 49.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
3.5 | 14.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
3.5 | 10.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
3.5 | 17.4 | GO:0050890 | cognition(GO:0050890) |
3.5 | 6.9 | GO:0072014 | proximal tubule development(GO:0072014) metanephric proximal tubule development(GO:0072237) |
3.5 | 13.8 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
3.5 | 27.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
3.4 | 3.4 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
3.4 | 3.4 | GO:0050666 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
3.4 | 10.3 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
3.4 | 3.4 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
3.4 | 13.7 | GO:0060594 | mammary gland specification(GO:0060594) |
3.4 | 13.6 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
3.4 | 20.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
3.3 | 23.4 | GO:0006531 | aspartate metabolic process(GO:0006531) |
3.3 | 3.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
3.3 | 6.6 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
3.3 | 9.9 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
3.3 | 3.3 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
3.3 | 6.6 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
3.3 | 13.0 | GO:0071321 | cellular response to cGMP(GO:0071321) |
3.3 | 22.8 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
3.2 | 35.3 | GO:0006983 | ER overload response(GO:0006983) |
3.2 | 16.0 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
3.2 | 9.6 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
3.2 | 9.6 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
3.2 | 3.2 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
3.2 | 9.5 | GO:0061055 | myotome development(GO:0061055) |
3.2 | 3.2 | GO:0097485 | neuron projection guidance(GO:0097485) |
3.2 | 9.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
3.2 | 47.4 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
3.1 | 3.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
3.1 | 12.6 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
3.1 | 9.4 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
3.1 | 18.7 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
3.1 | 15.6 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
3.1 | 99.6 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
3.1 | 24.9 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
3.1 | 6.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
3.1 | 3.1 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
3.0 | 36.6 | GO:0007625 | grooming behavior(GO:0007625) |
3.0 | 12.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
3.0 | 45.4 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
3.0 | 8.9 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
3.0 | 5.9 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
3.0 | 3.0 | GO:0072337 | modified amino acid transport(GO:0072337) |
3.0 | 5.9 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
2.9 | 38.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
2.9 | 5.9 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
2.9 | 5.9 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
2.9 | 17.5 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
2.9 | 11.6 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
2.9 | 2.9 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
2.9 | 5.8 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
2.9 | 26.0 | GO:0006554 | lysine catabolic process(GO:0006554) |
2.9 | 8.7 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
2.9 | 5.7 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
2.9 | 14.3 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
2.9 | 2.9 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
2.8 | 25.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
2.8 | 17.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
2.8 | 19.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.8 | 17.0 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
2.8 | 39.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
2.8 | 5.6 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
2.8 | 11.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
2.8 | 8.3 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
2.7 | 2.7 | GO:0002661 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
2.7 | 13.5 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
2.7 | 8.1 | GO:1905071 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
2.7 | 2.7 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
2.7 | 2.7 | GO:0071313 | cellular response to caffeine(GO:0071313) |
2.7 | 5.4 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
2.6 | 7.9 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
2.6 | 10.4 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
2.6 | 10.4 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
2.6 | 18.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
2.6 | 2.6 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
2.6 | 41.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
2.6 | 18.1 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
2.6 | 7.7 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
2.6 | 23.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
2.6 | 10.3 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
2.6 | 20.5 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
2.6 | 20.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
2.6 | 10.2 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
2.6 | 5.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
2.6 | 2.6 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
2.5 | 17.8 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
2.5 | 20.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
2.5 | 10.1 | GO:1903960 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
2.5 | 7.6 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
2.5 | 5.0 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
2.5 | 12.6 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
2.5 | 7.5 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
2.5 | 2.5 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
2.5 | 24.7 | GO:0060074 | synapse maturation(GO:0060074) |
2.5 | 9.9 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
2.5 | 34.5 | GO:0006198 | cAMP catabolic process(GO:0006198) |
2.5 | 14.8 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
2.5 | 7.4 | GO:0070781 | response to biotin(GO:0070781) |
2.4 | 44.0 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
2.4 | 14.5 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
2.4 | 16.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
2.4 | 7.2 | GO:0007141 | male meiosis I(GO:0007141) |
2.4 | 4.8 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
2.4 | 9.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
2.4 | 9.6 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
2.4 | 7.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
2.4 | 11.9 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
2.4 | 4.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
2.4 | 30.6 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
2.4 | 7.1 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
2.3 | 7.0 | GO:0051885 | positive regulation of anagen(GO:0051885) |
2.3 | 4.7 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
2.3 | 2.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
2.3 | 94.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
2.3 | 2.3 | GO:1902809 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
2.3 | 30.0 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
2.3 | 43.9 | GO:0097484 | dendrite extension(GO:0097484) |
2.3 | 38.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
2.3 | 6.9 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
2.3 | 4.6 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
2.3 | 152.8 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
2.3 | 11.4 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
2.3 | 9.1 | GO:0036269 | swimming behavior(GO:0036269) |
2.3 | 11.3 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
2.2 | 6.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
2.2 | 4.5 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
2.2 | 4.5 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
2.2 | 6.7 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
2.2 | 11.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
2.2 | 4.5 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
2.2 | 20.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
2.2 | 17.7 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
2.2 | 4.4 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
2.2 | 6.6 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
2.2 | 15.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
2.2 | 19.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
2.2 | 6.5 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
2.2 | 15.3 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
2.2 | 6.5 | GO:1904640 | response to methionine(GO:1904640) |
2.2 | 8.7 | GO:0015808 | L-alanine transport(GO:0015808) L-cystine transport(GO:0015811) |
2.2 | 2.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
2.2 | 4.3 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
2.2 | 43.2 | GO:0097503 | sialylation(GO:0097503) |
2.2 | 159.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
2.1 | 6.4 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
2.1 | 55.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
2.1 | 45.0 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
2.1 | 42.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
2.1 | 2.1 | GO:0099612 | protein localization to axon(GO:0099612) |
2.1 | 6.4 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
2.1 | 4.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
2.1 | 10.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
2.1 | 2.1 | GO:0060157 | urinary bladder development(GO:0060157) |
2.1 | 29.6 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
2.1 | 6.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
2.1 | 4.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
2.1 | 4.2 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
2.1 | 39.8 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
2.1 | 6.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
2.1 | 31.4 | GO:0015669 | gas transport(GO:0015669) |
2.1 | 4.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
2.1 | 8.3 | GO:0048710 | regulation of astrocyte differentiation(GO:0048710) |
2.1 | 20.7 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
2.1 | 20.6 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
2.1 | 2.1 | GO:0045026 | plasma membrane fusion(GO:0045026) |
2.1 | 4.1 | GO:0003342 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
2.1 | 6.2 | GO:1902846 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
2.1 | 4.1 | GO:0033559 | unsaturated fatty acid metabolic process(GO:0033559) |
2.0 | 8.2 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
2.0 | 4.1 | GO:0019233 | sensory perception of pain(GO:0019233) |
2.0 | 10.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
2.0 | 2.0 | GO:0006979 | response to oxidative stress(GO:0006979) |
2.0 | 12.2 | GO:0061525 | hindgut morphogenesis(GO:0007442) embryonic hindgut morphogenesis(GO:0048619) hindgut development(GO:0061525) |
2.0 | 14.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
2.0 | 4.1 | GO:0031960 | response to corticosteroid(GO:0031960) |
2.0 | 30.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
2.0 | 2.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
2.0 | 8.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
2.0 | 4.0 | GO:0007422 | peripheral nervous system development(GO:0007422) |
2.0 | 76.3 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
2.0 | 4.0 | GO:0060134 | prepulse inhibition(GO:0060134) |
2.0 | 4.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
2.0 | 8.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
2.0 | 4.0 | GO:1901671 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
2.0 | 2.0 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) purinergic nucleotide receptor signaling pathway(GO:0035590) |
2.0 | 2.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
2.0 | 31.8 | GO:0042417 | dopamine metabolic process(GO:0042417) |
2.0 | 2.0 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
2.0 | 11.8 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
2.0 | 7.9 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
2.0 | 11.8 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
2.0 | 7.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
2.0 | 5.9 | GO:0006026 | aminoglycan catabolic process(GO:0006026) glycosaminoglycan catabolic process(GO:0006027) |
2.0 | 5.9 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
1.9 | 33.1 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
1.9 | 3.9 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
1.9 | 15.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.9 | 7.8 | GO:0021997 | response to chlorate(GO:0010157) neural plate axis specification(GO:0021997) |
1.9 | 1.9 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
1.9 | 3.9 | GO:0070101 | positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
1.9 | 1.9 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
1.9 | 7.7 | GO:0097338 | response to clozapine(GO:0097338) |
1.9 | 11.5 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
1.9 | 5.7 | GO:0042713 | sperm ejaculation(GO:0042713) |
1.9 | 32.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
1.9 | 5.7 | GO:0010265 | SCF complex assembly(GO:0010265) |
1.9 | 1.9 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.9 | 22.5 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
1.9 | 5.6 | GO:0035898 | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development(GO:0035607) parathyroid hormone secretion(GO:0035898) regulation of parathyroid hormone secretion(GO:2000828) |
1.9 | 16.9 | GO:0072413 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
1.9 | 18.7 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
1.9 | 11.2 | GO:0051012 | microtubule sliding(GO:0051012) |
1.9 | 9.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.8 | 9.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.8 | 5.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.8 | 38.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.8 | 11.0 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
1.8 | 5.4 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
1.8 | 34.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
1.8 | 7.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
1.8 | 12.6 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.8 | 1.8 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
1.8 | 8.9 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
1.8 | 12.5 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.8 | 3.6 | GO:1990641 | response to iron ion starvation(GO:1990641) |
1.8 | 12.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.8 | 28.4 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
1.8 | 1.8 | GO:2000364 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
1.8 | 5.3 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
1.8 | 15.8 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
1.8 | 8.8 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.8 | 26.3 | GO:2001273 | regulation of glucose import in response to insulin stimulus(GO:2001273) |
1.8 | 21.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
1.8 | 5.3 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
1.7 | 21.0 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
1.7 | 19.2 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.7 | 3.5 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
1.7 | 12.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
1.7 | 29.3 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.7 | 1.7 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
1.7 | 6.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
1.7 | 3.4 | GO:1903413 | cellular response to bile acid(GO:1903413) |
1.7 | 22.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.7 | 5.1 | GO:0038127 | ERBB signaling pathway(GO:0038127) |
1.7 | 10.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
1.7 | 3.4 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
1.7 | 8.4 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
1.7 | 5.0 | GO:0009183 | ADP biosynthetic process(GO:0006172) purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
1.7 | 1.7 | GO:1903169 | regulation of calcium ion transmembrane transport(GO:1903169) |
1.7 | 50.2 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
1.7 | 1.7 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
1.7 | 3.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.7 | 6.6 | GO:0042551 | neuron maturation(GO:0042551) |
1.7 | 5.0 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
1.7 | 1.7 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
1.7 | 3.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
1.6 | 3.3 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
1.6 | 31.2 | GO:0034389 | lipid particle organization(GO:0034389) |
1.6 | 4.9 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
1.6 | 4.9 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
1.6 | 3.2 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.6 | 1.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
1.6 | 19.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.6 | 3.2 | GO:0003407 | neural retina development(GO:0003407) |
1.6 | 9.6 | GO:0070375 | ERK5 cascade(GO:0070375) |
1.6 | 8.0 | GO:0001842 | neural fold formation(GO:0001842) |
1.6 | 54.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.6 | 7.9 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
1.6 | 1.6 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
1.6 | 1.6 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
1.6 | 1.6 | GO:0022410 | circadian sleep/wake cycle process(GO:0022410) |
1.6 | 3.1 | GO:1990637 | response to prolactin(GO:1990637) |
1.6 | 31.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.5 | 13.9 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
1.5 | 1.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
1.5 | 1.5 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
1.5 | 6.1 | GO:0009386 | translational attenuation(GO:0009386) |
1.5 | 9.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
1.5 | 3.0 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
1.5 | 3.0 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
1.5 | 4.5 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
1.5 | 16.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.5 | 1.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
1.5 | 3.0 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) xanthine metabolic process(GO:0046110) |
1.5 | 4.5 | GO:0003197 | endocardial cushion development(GO:0003197) |
1.5 | 1.5 | GO:1900238 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.5 | 5.9 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
1.5 | 1.5 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
1.5 | 10.3 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
1.5 | 13.3 | GO:0006477 | protein sulfation(GO:0006477) |
1.5 | 16.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.5 | 7.4 | GO:0099504 | synaptic vesicle cycle(GO:0099504) |
1.5 | 4.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.5 | 5.8 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
1.5 | 2.9 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.5 | 7.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
1.4 | 4.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.4 | 8.7 | GO:0071625 | vocalization behavior(GO:0071625) |
1.4 | 2.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.4 | 7.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.4 | 2.9 | GO:0048469 | cell maturation(GO:0048469) |
1.4 | 7.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
1.4 | 18.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
1.4 | 2.9 | GO:0030199 | collagen fibril organization(GO:0030199) |
1.4 | 2.8 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
1.4 | 8.5 | GO:0019563 | glycerol catabolic process(GO:0019563) |
1.4 | 4.2 | GO:0002880 | microglial cell activation involved in immune response(GO:0002282) chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
1.4 | 8.4 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
1.4 | 4.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
1.4 | 4.2 | GO:0061760 | antifungal innate immune response(GO:0061760) |
1.4 | 4.2 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
1.4 | 5.5 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
1.4 | 2.8 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
1.4 | 4.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.4 | 2.7 | GO:0070426 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
1.4 | 13.6 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
1.3 | 1.3 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
1.3 | 8.0 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
1.3 | 6.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.3 | 11.8 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
1.3 | 10.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.3 | 2.6 | GO:0014044 | Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
1.3 | 10.4 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
1.3 | 11.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.3 | 1.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
1.3 | 6.5 | GO:0006071 | glycerol metabolic process(GO:0006071) |
1.3 | 9.0 | GO:0097369 | sodium ion import(GO:0097369) |
1.3 | 9.0 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
1.3 | 3.9 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.3 | 9.0 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
1.3 | 6.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.3 | 7.6 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.3 | 3.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.3 | 11.4 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
1.3 | 5.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
1.3 | 59.2 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
1.3 | 5.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.3 | 6.3 | GO:0042426 | choline catabolic process(GO:0042426) |
1.2 | 5.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
1.2 | 1.2 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.2 | 5.0 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
1.2 | 2.5 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
1.2 | 22.1 | GO:0033622 | integrin activation(GO:0033622) |
1.2 | 2.5 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
1.2 | 3.7 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.2 | 9.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.2 | 6.1 | GO:2000194 | regulation of female gonad development(GO:2000194) |
1.2 | 65.7 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
1.2 | 7.3 | GO:0071105 | response to interleukin-11(GO:0071105) |
1.2 | 2.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
1.2 | 6.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.2 | 15.7 | GO:0010934 | macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) positive regulation of macrophage cytokine production(GO:0060907) |
1.2 | 12.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.2 | 6.0 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
1.2 | 12.0 | GO:0035878 | nail development(GO:0035878) |
1.2 | 2.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.2 | 3.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.2 | 2.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
1.2 | 14.3 | GO:0030575 | nuclear body organization(GO:0030575) |
1.2 | 6.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.2 | 3.6 | GO:0097359 | UDP-glucosylation(GO:0097359) |
1.2 | 27.4 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
1.2 | 16.6 | GO:0007530 | sex determination(GO:0007530) |
1.2 | 5.9 | GO:0061072 | iris morphogenesis(GO:0061072) |
1.2 | 7.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
1.2 | 5.9 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
1.2 | 7.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
1.2 | 1.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
1.2 | 5.9 | GO:0045023 | G0 to G1 transition(GO:0045023) |
1.2 | 4.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.2 | 9.3 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
1.2 | 2.3 | GO:1903319 | positive regulation of protein maturation(GO:1903319) |
1.2 | 3.5 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
1.2 | 10.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
1.1 | 5.7 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
1.1 | 3.4 | GO:0001881 | receptor recycling(GO:0001881) |
1.1 | 1.1 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
1.1 | 10.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
1.1 | 6.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.1 | 1.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.1 | 1.1 | GO:0019835 | cytolysis(GO:0019835) |
1.1 | 4.5 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
1.1 | 2.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
1.1 | 2.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.1 | 4.5 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.1 | 5.6 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
1.1 | 1.1 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
1.1 | 6.7 | GO:0090042 | tubulin deacetylation(GO:0090042) |
1.1 | 6.7 | GO:0018343 | protein farnesylation(GO:0018343) |
1.1 | 4.5 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
1.1 | 5.6 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
1.1 | 11.1 | GO:0046520 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
1.1 | 5.5 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
1.1 | 4.4 | GO:0002215 | defense response to nematode(GO:0002215) |
1.1 | 8.8 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
1.1 | 1.1 | GO:0060290 | transdifferentiation(GO:0060290) |
1.1 | 11.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.1 | 18.7 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
1.1 | 4.4 | GO:0019046 | release from viral latency(GO:0019046) |
1.1 | 7.7 | GO:0008542 | visual learning(GO:0008542) |
1.1 | 9.9 | GO:0043379 | memory T cell differentiation(GO:0043379) |
1.1 | 7.6 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
1.1 | 1.1 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
1.1 | 1.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.1 | 10.8 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
1.1 | 1.1 | GO:2001225 | regulation of chloride transport(GO:2001225) |
1.1 | 5.3 | GO:1901091 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
1.1 | 2.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.1 | 2.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.1 | 5.3 | GO:0006007 | glucose catabolic process(GO:0006007) |
1.1 | 3.2 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
1.1 | 8.4 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
1.1 | 2.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.0 | 5.2 | GO:1901998 | toxin transport(GO:1901998) |
1.0 | 1.0 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
1.0 | 6.3 | GO:1904427 | positive regulation of calcium ion transmembrane transport(GO:1904427) |
1.0 | 8.3 | GO:0009304 | tRNA transcription(GO:0009304) |
1.0 | 2.1 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) |
1.0 | 1.0 | GO:0044010 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
1.0 | 8.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
1.0 | 72.1 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
1.0 | 1.0 | GO:0001975 | response to amphetamine(GO:0001975) |
1.0 | 2.1 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
1.0 | 4.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
1.0 | 1.0 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
1.0 | 20.3 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
1.0 | 12.2 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
1.0 | 4.0 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
1.0 | 3.0 | GO:0051013 | microtubule severing(GO:0051013) |
1.0 | 3.0 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
1.0 | 2.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
1.0 | 1.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.0 | 2.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.0 | 3.0 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
1.0 | 2.0 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
1.0 | 2.9 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) |
1.0 | 4.9 | GO:1902904 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) clathrin coat disassembly(GO:0072318) negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
1.0 | 10.7 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
1.0 | 1.0 | GO:0071711 | basement membrane organization(GO:0071711) |
1.0 | 5.8 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
1.0 | 1.9 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
1.0 | 38.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
1.0 | 17.3 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
1.0 | 10.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
1.0 | 19.1 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
1.0 | 1.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.9 | 5.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.9 | 3.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.9 | 6.6 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.9 | 0.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.9 | 1.9 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.9 | 3.8 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.9 | 0.9 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.9 | 2.8 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.9 | 1.9 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.9 | 1.9 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.9 | 3.7 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.9 | 3.7 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.9 | 1.8 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.9 | 2.7 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.9 | 2.7 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.9 | 4.6 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.9 | 0.9 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.9 | 1.8 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.9 | 2.7 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.9 | 1.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.9 | 3.6 | GO:0015705 | iodide transport(GO:0015705) |
0.9 | 2.6 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.9 | 1.8 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.9 | 10.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.9 | 2.6 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.9 | 3.5 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.9 | 3.5 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.9 | 2.6 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.9 | 5.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.9 | 7.8 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.9 | 0.9 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.9 | 5.2 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.9 | 6.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.9 | 8.6 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.9 | 3.4 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.9 | 4.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.9 | 7.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.9 | 5.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.8 | 21.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.8 | 2.5 | GO:1904847 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.8 | 1.7 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
0.8 | 1.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.8 | 1.7 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.8 | 3.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.8 | 2.5 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.8 | 5.8 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.8 | 2.5 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.8 | 2.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.8 | 1.7 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.8 | 0.8 | GO:0007549 | dosage compensation(GO:0007549) |
0.8 | 4.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.8 | 4.9 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.8 | 2.4 | GO:0030432 | peristalsis(GO:0030432) |
0.8 | 4.1 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.8 | 6.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.8 | 0.8 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.8 | 4.0 | GO:0071422 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
0.8 | 1.6 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.8 | 4.8 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.8 | 0.8 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.8 | 30.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.8 | 1.6 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.8 | 2.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.8 | 36.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.8 | 2.4 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.8 | 6.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.8 | 3.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.8 | 30.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.8 | 1.6 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.8 | 7.1 | GO:0015886 | heme transport(GO:0015886) |
0.8 | 3.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.8 | 0.8 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.8 | 1.6 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.8 | 3.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.8 | 18.6 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.8 | 1.5 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.8 | 1.5 | GO:0044782 | cilium organization(GO:0044782) |
0.8 | 2.3 | GO:0086097 | renin-angiotensin regulation of aldosterone production(GO:0002018) mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.8 | 3.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.8 | 3.8 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.8 | 7.7 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.8 | 0.8 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.8 | 4.6 | GO:0050804 | modulation of synaptic transmission(GO:0050804) |
0.8 | 0.8 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.8 | 4.5 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.8 | 3.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.8 | 7.5 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.7 | 8.2 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.7 | 3.7 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.7 | 3.7 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.7 | 0.7 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.7 | 3.7 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.7 | 3.7 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.7 | 4.4 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.7 | 13.9 | GO:0003341 | cilium movement(GO:0003341) |
0.7 | 4.4 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.7 | 0.7 | GO:0007612 | learning(GO:0007612) |
0.7 | 5.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.7 | 0.7 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
0.7 | 2.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.7 | 11.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.7 | 0.7 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.7 | 1.4 | GO:1902075 | cellular response to salt(GO:1902075) response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.7 | 5.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.7 | 1.4 | GO:0086070 | SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.7 | 2.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.7 | 2.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.7 | 9.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.7 | 0.7 | GO:0048664 | neuron fate determination(GO:0048664) |
0.7 | 2.8 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.7 | 2.1 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.7 | 4.9 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.7 | 1.4 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.7 | 6.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.7 | 4.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.7 | 4.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.7 | 3.5 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.7 | 38.8 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.7 | 1.4 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.7 | 20.7 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.7 | 1.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.7 | 9.6 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.7 | 5.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.7 | 0.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.7 | 17.7 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.7 | 3.4 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
0.7 | 6.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.7 | 4.0 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.7 | 1.3 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.7 | 1.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.7 | 4.0 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.7 | 15.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.7 | 12.7 | GO:0031167 | rRNA methylation(GO:0031167) |
0.7 | 20.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.7 | 25.3 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.7 | 3.3 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.7 | 2.7 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.7 | 0.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.7 | 3.3 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.7 | 1.3 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) negative regulation of cardiac muscle contraction(GO:0055118) |
0.7 | 7.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.7 | 13.1 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.7 | 0.7 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.6 | 13.6 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.6 | 1.9 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.6 | 17.4 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.6 | 5.2 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.6 | 1.3 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.6 | 1.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.6 | 3.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.6 | 1.9 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.6 | 2.6 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.6 | 1.9 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.6 | 1.9 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.6 | 1.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.6 | 10.1 | GO:0032438 | melanosome organization(GO:0032438) |
0.6 | 4.4 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.6 | 1.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.6 | 1.2 | GO:0043385 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.6 | 0.6 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.6 | 1.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.6 | 1.8 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.6 | 0.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.6 | 2.4 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.6 | 4.8 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.6 | 2.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.6 | 0.6 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.6 | 2.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.6 | 1.8 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.6 | 1.8 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.6 | 1.8 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.6 | 4.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.6 | 2.9 | GO:0006690 | icosanoid metabolic process(GO:0006690) fatty acid derivative metabolic process(GO:1901568) |
0.6 | 4.7 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.6 | 2.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.6 | 9.3 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.6 | 1.7 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.6 | 1.2 | GO:0032095 | regulation of response to food(GO:0032095) |
0.6 | 7.5 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.6 | 7.5 | GO:0032196 | transposition(GO:0032196) |
0.6 | 3.4 | GO:0003360 | brainstem development(GO:0003360) |
0.6 | 1.1 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.6 | 2.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.6 | 0.6 | GO:0002874 | positive regulation of chronic inflammatory response(GO:0002678) regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.6 | 6.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.6 | 0.6 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.6 | 1.7 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.6 | 2.3 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
0.6 | 1.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.6 | 1.7 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.6 | 1.7 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.6 | 3.3 | GO:0022038 | corpus callosum development(GO:0022038) |
0.6 | 2.8 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.5 | 1.6 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.5 | 1.1 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
0.5 | 1.1 | GO:0060398 | mineralocorticoid receptor signaling pathway(GO:0031959) regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.5 | 1.6 | GO:1903430 | negative regulation of cell maturation(GO:1903430) |
0.5 | 2.7 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.5 | 0.5 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
0.5 | 2.7 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.5 | 1.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 0.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.5 | 1.1 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.5 | 6.9 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.5 | 1.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.5 | 2.1 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.5 | 2.6 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.5 | 2.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.5 | 15.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.5 | 1.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.5 | 3.1 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.5 | 1.6 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.5 | 3.1 | GO:0001554 | luteolysis(GO:0001554) |
0.5 | 1.6 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.5 | 3.6 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.5 | 6.6 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.5 | 11.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.5 | 2.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.5 | 5.1 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.5 | 0.5 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.5 | 1.0 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
0.5 | 6.0 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.5 | 11.0 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.5 | 4.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.5 | 6.5 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.5 | 2.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.5 | 1.0 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.5 | 1.5 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.5 | 4.5 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.5 | 3.0 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.5 | 3.0 | GO:0000050 | urea cycle(GO:0000050) |
0.5 | 4.9 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.5 | 0.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.5 | 1.5 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.5 | 1.5 | GO:0038001 | paracrine signaling(GO:0038001) |
0.5 | 1.9 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.5 | 1.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.5 | 4.8 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.5 | 2.9 | GO:0071417 | cellular response to hormone stimulus(GO:0032870) cellular response to organonitrogen compound(GO:0071417) |
0.5 | 1.9 | GO:0046502 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
0.5 | 0.5 | GO:0042756 | drinking behavior(GO:0042756) |
0.5 | 7.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.5 | 1.0 | GO:0015870 | acetylcholine transport(GO:0015870) |
0.5 | 0.9 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.5 | 4.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.5 | 0.5 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.5 | 2.3 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.5 | 1.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.5 | 4.2 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.5 | 0.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.5 | 3.7 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.5 | 25.3 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) |
0.5 | 3.7 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.5 | 0.9 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.5 | 3.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.5 | 0.9 | GO:0016048 | detection of temperature stimulus(GO:0016048) sensory perception of temperature stimulus(GO:0050951) |
0.5 | 4.6 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.5 | 6.8 | GO:0043113 | receptor clustering(GO:0043113) |
0.5 | 18.1 | GO:0046323 | glucose import(GO:0046323) |
0.5 | 1.8 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.5 | 1.8 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.4 | 1.8 | GO:0015942 | formate metabolic process(GO:0015942) |
0.4 | 1.3 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.4 | 1.3 | GO:0051414 | response to cortisol(GO:0051414) |
0.4 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 8.9 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
0.4 | 1.8 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.4 | 3.5 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 3.5 | GO:0032329 | L-serine transport(GO:0015825) serine transport(GO:0032329) |
0.4 | 0.9 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.4 | 1.3 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.4 | 2.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 4.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.4 | 2.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.4 | 4.3 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.4 | 1.3 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.4 | 1.3 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.4 | 0.8 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.4 | 3.8 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.4 | 3.8 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.4 | 9.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.4 | 0.8 | GO:0032868 | response to insulin(GO:0032868) |
0.4 | 0.4 | GO:0035864 | response to potassium ion(GO:0035864) |
0.4 | 0.8 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.4 | 30.5 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.4 | 1.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.4 | 2.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.4 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.4 | 0.8 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.4 | 0.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.4 | 1.6 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.4 | 2.0 | GO:0042476 | odontogenesis(GO:0042476) |
0.4 | 3.9 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.4 | 3.1 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.4 | 1.9 | GO:0070986 | left/right axis specification(GO:0070986) |
0.4 | 0.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.4 | 1.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.4 | 0.8 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.4 | 1.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.4 | 1.1 | GO:0097056 | seryl-tRNA aminoacylation(GO:0006434) selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
0.4 | 1.5 | GO:0042335 | cuticle development(GO:0042335) |
0.4 | 0.7 | GO:0071623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.4 | 6.7 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.4 | 1.8 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.4 | 1.8 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.4 | 0.7 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.4 | 0.7 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.4 | 0.7 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.4 | 2.2 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.4 | 1.1 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.4 | 1.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.4 | 2.2 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.4 | 8.2 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.4 | 0.7 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.4 | 4.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.4 | 21.2 | GO:0007626 | locomotory behavior(GO:0007626) |
0.4 | 1.8 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.4 | 1.8 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.4 | 4.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 2.4 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.3 | 1.0 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.3 | 1.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 1.0 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.3 | 0.3 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.3 | 0.7 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.3 | 0.7 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.3 | 1.0 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.3 | 5.5 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.3 | 4.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.3 | 27.5 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.3 | 1.0 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.3 | 3.4 | GO:0007512 | adult heart development(GO:0007512) |
0.3 | 1.3 | GO:0070942 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
0.3 | 0.7 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 1.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 4.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.3 | 2.0 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.3 | 1.3 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 0.6 | GO:0044805 | late nucleophagy(GO:0044805) |
0.3 | 1.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 1.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 2.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 1.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 0.9 | GO:0021988 | olfactory lobe development(GO:0021988) |
0.3 | 0.6 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.3 | 2.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 4.7 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.3 | 1.2 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.3 | 1.8 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.3 | 2.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.3 | 0.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 1.5 | GO:0071476 | hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
0.3 | 3.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 3.0 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.3 | 1.2 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.3 | 0.6 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.3 | 2.1 | GO:0051197 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.3 | 1.5 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.3 | 0.6 | GO:0043132 | NAD transport(GO:0043132) |
0.3 | 1.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.3 | 1.8 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.3 | 1.5 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.3 | 1.2 | GO:0030282 | bone mineralization(GO:0030282) |
0.3 | 0.6 | GO:0002276 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
0.3 | 3.8 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.3 | 0.9 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.3 | 3.7 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.3 | 1.4 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.3 | 3.6 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.3 | 0.8 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
0.3 | 3.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.3 | 0.5 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) |
0.3 | 1.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 4.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.3 | 0.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.3 | 1.1 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.3 | 0.3 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.3 | 1.0 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.3 | 0.5 | GO:0060513 | prostatic bud formation(GO:0060513) negative regulation of prostatic bud formation(GO:0060686) |
0.3 | 2.1 | GO:0007340 | acrosome reaction(GO:0007340) |
0.3 | 1.5 | GO:0042073 | intraciliary transport(GO:0042073) |
0.3 | 1.8 | GO:1902416 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) |
0.3 | 2.5 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.3 | 0.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 1.0 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 0.8 | GO:0010447 | response to acidic pH(GO:0010447) |
0.2 | 1.2 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.2 | 0.7 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.2 | 1.2 | GO:0090267 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.2 | 1.7 | GO:0045007 | depurination(GO:0045007) |
0.2 | 1.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 3.5 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 1.9 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.9 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.2 | 0.7 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.2 | 0.5 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.2 | 0.5 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.2 | 0.5 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.2 | 0.5 | GO:0061053 | somite development(GO:0061053) |
0.2 | 1.4 | GO:0045766 | positive regulation of angiogenesis(GO:0045766) |
0.2 | 0.5 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 0.9 | GO:0021543 | pallium development(GO:0021543) |
0.2 | 0.7 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.2 | 0.9 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.2 | 1.1 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.2 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 1.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 0.4 | GO:0051099 | positive regulation of binding(GO:0051099) |
0.2 | 26.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 1.9 | GO:0006813 | potassium ion transport(GO:0006813) |
0.2 | 0.4 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.2 | 0.4 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.2 | 2.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 3.6 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 1.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 1.0 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.2 | 0.8 | GO:0071482 | cellular response to UV(GO:0034644) cellular response to light stimulus(GO:0071482) |
0.2 | 2.3 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 5.4 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.2 | 4.0 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 2.1 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.2 | 0.2 | GO:1901343 | negative regulation of vasculature development(GO:1901343) |
0.2 | 1.9 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.2 | 0.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 1.1 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 9.2 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.2 | 7.4 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.2 | 3.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 3.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 2.3 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.2 | 0.5 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 0.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 2.8 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 3.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.2 | 0.3 | GO:0002581 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.2 | 0.5 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.2 | 2.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 1.2 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.2 | 1.2 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 0.8 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.8 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.2 | 1.0 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.2 | 0.8 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.2 | 1.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 6.4 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.2 | 0.3 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.2 | 1.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 0.8 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 | 0.3 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 3.4 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.6 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.1 | 0.8 | GO:0098761 | interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
0.1 | 5.0 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 6.6 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 2.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.7 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 4.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 1.0 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.1 | 33.8 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.1 | 0.4 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.1 | 0.4 | GO:0007595 | lactation(GO:0007595) |
0.1 | 0.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.9 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.7 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.1 | 0.4 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 1.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.1 | 0.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.9 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.7 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 4.1 | GO:0009583 | detection of light stimulus(GO:0009583) |
0.1 | 0.3 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 1.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.9 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 1.0 | GO:0015937 | coenzyme A metabolic process(GO:0015936) coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.3 | GO:0001759 | organ induction(GO:0001759) |
0.1 | 2.4 | GO:0045453 | bone resorption(GO:0045453) |
0.1 | 0.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.6 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.9 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.5 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.6 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 1.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 1.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 5.3 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.1 | 1.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.4 | GO:0051899 | membrane depolarization(GO:0051899) |
0.1 | 0.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.2 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.1 | 0.2 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 0.4 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.1 | GO:0034599 | cellular response to oxidative stress(GO:0034599) |
0.1 | 0.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.1 | 1.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.9 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.1 | 0.8 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 1.0 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.4 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.1 | GO:0044062 | regulation of excretion(GO:0044062) |
0.0 | 0.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.2 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.0 | 0.2 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.2 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.0 | 0.2 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.1 | GO:0071554 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.1 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.0 | 0.7 | GO:0070423 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
0.0 | 0.0 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.0 | 0.3 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.1 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.0 | 0.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.0 | 0.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.2 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 1.3 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.2 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.0 | 0.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.0 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
33.6 | 100.7 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
15.9 | 254.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
15.8 | 47.5 | GO:0072534 | perineuronal net(GO:0072534) |
15.0 | 75.0 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
10.1 | 40.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
9.4 | 47.2 | GO:0045298 | tubulin complex(GO:0045298) |
9.4 | 56.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
8.6 | 60.3 | GO:0032584 | growth cone membrane(GO:0032584) |
8.5 | 50.9 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
8.1 | 32.2 | GO:0031673 | H zone(GO:0031673) |
8.0 | 24.0 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
7.9 | 63.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
7.8 | 39.1 | GO:0036128 | CatSper complex(GO:0036128) |
7.5 | 52.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
7.4 | 89.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
7.4 | 7.4 | GO:0019034 | viral replication complex(GO:0019034) |
6.6 | 112.1 | GO:0043194 | axon initial segment(GO:0043194) |
6.3 | 25.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
6.3 | 56.4 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
6.2 | 87.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
6.1 | 43.0 | GO:0033269 | internode region of axon(GO:0033269) |
6.0 | 30.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
5.5 | 16.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
5.3 | 21.3 | GO:0033268 | node of Ranvier(GO:0033268) |
5.2 | 20.6 | GO:0014802 | terminal cisterna(GO:0014802) |
5.0 | 19.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
4.7 | 32.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
4.7 | 32.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
4.7 | 79.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
4.5 | 53.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
4.4 | 17.8 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
4.4 | 39.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
4.0 | 20.2 | GO:0030673 | axolemma(GO:0030673) |
4.0 | 276.8 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
4.0 | 51.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
3.9 | 196.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
3.9 | 23.5 | GO:0097449 | astrocyte projection(GO:0097449) |
3.9 | 70.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
3.9 | 11.8 | GO:0031251 | PAN complex(GO:0031251) |
3.9 | 3.9 | GO:0043291 | RAVE complex(GO:0043291) |
3.9 | 31.0 | GO:0045179 | apical cortex(GO:0045179) |
3.8 | 15.3 | GO:0097224 | sperm connecting piece(GO:0097224) |
3.8 | 30.1 | GO:0097386 | glial cell projection(GO:0097386) |
3.8 | 71.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
3.7 | 194.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
3.7 | 84.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
3.7 | 29.3 | GO:0033270 | paranode region of axon(GO:0033270) |
3.6 | 36.3 | GO:0031209 | SCAR complex(GO:0031209) |
3.4 | 20.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
3.4 | 130.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
3.4 | 24.0 | GO:0005955 | calcineurin complex(GO:0005955) |
3.4 | 23.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
3.4 | 23.5 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
3.3 | 16.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
3.3 | 16.4 | GO:0044327 | dendritic spine head(GO:0044327) |
3.2 | 3.2 | GO:1902636 | kinociliary basal body(GO:1902636) |
3.2 | 9.5 | GO:0044609 | DBIRD complex(GO:0044609) |
3.1 | 34.2 | GO:0043083 | synaptic cleft(GO:0043083) |
3.1 | 538.4 | GO:0030426 | growth cone(GO:0030426) |
3.1 | 3.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
3.1 | 657.3 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
3.0 | 27.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
3.0 | 75.0 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
2.9 | 26.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
2.9 | 49.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
2.8 | 293.6 | GO:0043204 | perikaryon(GO:0043204) |
2.7 | 209.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
2.7 | 38.0 | GO:0097227 | sperm annulus(GO:0097227) |
2.7 | 18.6 | GO:0097209 | epidermal lamellar body(GO:0097209) |
2.6 | 52.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
2.6 | 26.0 | GO:0097427 | microtubule bundle(GO:0097427) |
2.5 | 15.2 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
2.5 | 10.1 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
2.5 | 10.1 | GO:0070695 | FHF complex(GO:0070695) |
2.5 | 5.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
2.5 | 14.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
2.4 | 7.2 | GO:0097440 | apical dendrite(GO:0097440) |
2.4 | 7.2 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
2.4 | 23.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
2.4 | 11.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.3 | 4.5 | GO:0005883 | neurofilament(GO:0005883) |
2.0 | 17.9 | GO:0008091 | spectrin(GO:0008091) |
2.0 | 5.9 | GO:0098559 | cytoplasmic side of endosome membrane(GO:0010009) cytoplasmic side of early endosome membrane(GO:0098559) |
1.9 | 5.8 | GO:0097447 | dendritic tree(GO:0097447) |
1.9 | 15.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
1.9 | 5.6 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
1.9 | 5.6 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
1.8 | 5.4 | GO:0036398 | TCR signalosome(GO:0036398) |
1.8 | 21.1 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
1.7 | 8.6 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
1.7 | 10.2 | GO:0060076 | excitatory synapse(GO:0060076) |
1.7 | 1.7 | GO:0070382 | exocytic vesicle(GO:0070382) |
1.7 | 1.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.7 | 1.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.6 | 51.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.6 | 3.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
1.5 | 15.4 | GO:0071953 | elastic fiber(GO:0071953) |
1.5 | 10.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.5 | 4.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.5 | 6.1 | GO:0045160 | myosin I complex(GO:0045160) |
1.5 | 75.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.5 | 13.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
1.5 | 6.0 | GO:1990246 | uniplex complex(GO:1990246) |
1.5 | 100.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.5 | 37.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.5 | 8.8 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
1.4 | 8.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.4 | 28.8 | GO:0097546 | ciliary base(GO:0097546) |
1.4 | 5.7 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
1.4 | 5.7 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
1.4 | 17.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.4 | 23.5 | GO:0043198 | dendritic shaft(GO:0043198) |
1.3 | 24.2 | GO:0005922 | connexon complex(GO:0005922) |
1.3 | 13.1 | GO:0000800 | lateral element(GO:0000800) |
1.3 | 5.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.3 | 6.5 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
1.3 | 9.0 | GO:0043203 | axon hillock(GO:0043203) |
1.3 | 10.1 | GO:0098845 | postsynaptic endosome(GO:0098845) |
1.2 | 3.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.2 | 3.6 | GO:0016013 | syntrophin complex(GO:0016013) |
1.2 | 3.6 | GO:0043159 | acrosomal matrix(GO:0043159) |
1.2 | 10.7 | GO:0033391 | chromatoid body(GO:0033391) |
1.2 | 5.9 | GO:0034457 | Mpp10 complex(GO:0034457) |
1.2 | 188.1 | GO:0098793 | presynapse(GO:0098793) |
1.2 | 33.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
1.2 | 11.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
1.1 | 1.1 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
1.1 | 165.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
1.1 | 8.9 | GO:0035976 | AP1 complex(GO:0035976) |
1.1 | 4.4 | GO:0031417 | NatC complex(GO:0031417) |
1.1 | 15.4 | GO:0005858 | axonemal dynein complex(GO:0005858) |
1.1 | 7.6 | GO:0034464 | BBSome(GO:0034464) |
1.1 | 3.2 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
1.1 | 35.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
1.1 | 5.3 | GO:0044853 | plasma membrane raft(GO:0044853) |
1.0 | 8.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
1.0 | 5.1 | GO:0070847 | core mediator complex(GO:0070847) |
1.0 | 6.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.0 | 5.0 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
1.0 | 3.0 | GO:0016938 | kinesin I complex(GO:0016938) |
1.0 | 8.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.0 | 10.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.0 | 63.5 | GO:0036064 | ciliary basal body(GO:0036064) |
0.9 | 30.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.9 | 6.6 | GO:0072487 | MSL complex(GO:0072487) |
0.9 | 5.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.9 | 0.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.9 | 2.7 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.9 | 0.9 | GO:0000806 | Y chromosome(GO:0000806) |
0.9 | 8.8 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.9 | 3.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.9 | 7.8 | GO:0045180 | basal cortex(GO:0045180) |
0.9 | 37.2 | GO:0005871 | kinesin complex(GO:0005871) |
0.9 | 1.7 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.9 | 3.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.9 | 3.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.9 | 11.9 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.8 | 3.4 | GO:0060091 | kinocilium(GO:0060091) |
0.8 | 5.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.8 | 19.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.8 | 3.3 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.8 | 8.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.8 | 2.5 | GO:0098536 | deuterosome(GO:0098536) |
0.8 | 23.7 | GO:0008305 | integrin complex(GO:0008305) |
0.8 | 2.3 | GO:0031045 | dense core granule(GO:0031045) |
0.8 | 2.3 | GO:0031213 | RSF complex(GO:0031213) |
0.8 | 2.3 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.7 | 1.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.7 | 2.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.7 | 2.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.7 | 14.9 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.7 | 7.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.7 | 11.6 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.7 | 4.8 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.7 | 16.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.7 | 19.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.7 | 10.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.7 | 150.1 | GO:0043025 | neuronal cell body(GO:0043025) |
0.7 | 132.0 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.6 | 24.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.6 | 11.0 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.6 | 7.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.6 | 4.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.6 | 8.1 | GO:0030478 | actin cap(GO:0030478) |
0.6 | 11.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.6 | 3.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.6 | 12.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.6 | 3.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.6 | 7.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.6 | 1.8 | GO:0030897 | HOPS complex(GO:0030897) |
0.6 | 1.2 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.6 | 0.6 | GO:0055087 | Ski complex(GO:0055087) |
0.6 | 4.5 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.6 | 1.7 | GO:0097182 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.5 | 4.9 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 2.7 | GO:0072687 | meiotic spindle(GO:0072687) |
0.5 | 2.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.5 | 2.6 | GO:0030427 | site of polarized growth(GO:0030427) |
0.5 | 7.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.5 | 1.5 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.5 | 3.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.5 | 2.5 | GO:0089701 | U2AF(GO:0089701) |
0.5 | 1.0 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.5 | 0.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.5 | 7.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.5 | 2.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.5 | 3.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.5 | 2.9 | GO:1990130 | Iml1 complex(GO:1990130) |
0.5 | 3.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.5 | 9.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.5 | 1.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.4 | 5.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.4 | 1.7 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 6.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 2.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.4 | 1.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.4 | 11.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 10.7 | GO:0030057 | desmosome(GO:0030057) |
0.4 | 2.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.4 | 1.6 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.4 | 15.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.4 | 2.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 4.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 73.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.4 | 1.5 | GO:1990752 | microtubule end(GO:1990752) |
0.4 | 1.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.4 | 1.8 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.4 | 0.7 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.4 | 3.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.4 | 4.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.4 | 1.4 | GO:0000801 | central element(GO:0000801) |
0.4 | 2.8 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 27.3 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.3 | 2.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.3 | 18.8 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 3.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 10.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.3 | 1.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 2.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 1.6 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.3 | 54.6 | GO:0043235 | receptor complex(GO:0043235) |
0.3 | 1.6 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 1.9 | GO:1990037 | Lewy body core(GO:1990037) |
0.3 | 27.4 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.3 | 1.8 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 0.9 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.3 | 1.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 1.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 11.0 | GO:0005902 | microvillus(GO:0005902) |
0.3 | 1.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 2.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 1.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 1.3 | GO:0001652 | granular component(GO:0001652) |
0.3 | 63.3 | GO:0045202 | synapse(GO:0045202) |
0.3 | 0.8 | GO:0034657 | GID complex(GO:0034657) |
0.3 | 11.8 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 1.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 2.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 3.0 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.2 | 7.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 1.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.2 | 1.4 | GO:0070187 | telosome(GO:0070187) |
0.2 | 29.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 17.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 1.1 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.2 | 1.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 1.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.8 | GO:0002177 | manchette(GO:0002177) |
0.2 | 1.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 10.3 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 2.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 11.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 17.0 | GO:0097223 | sperm part(GO:0097223) |
0.2 | 0.8 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.2 | 1.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 1.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.2 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 4.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 8.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 17.4 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 1.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.7 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.5 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 1.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.5 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 9.5 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 3.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.3 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.1 | 1.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 5.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.3 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 0.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 175.9 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.6 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 1.0 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.0 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.3 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
33.6 | 100.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
19.3 | 58.0 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
14.5 | 58.0 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
14.4 | 230.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
12.4 | 62.2 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
11.6 | 58.2 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
10.9 | 21.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
10.4 | 31.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
10.2 | 30.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
9.9 | 29.8 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
9.4 | 103.2 | GO:0030274 | LIM domain binding(GO:0030274) |
9.4 | 56.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
9.2 | 36.8 | GO:0099609 | microtubule lateral binding(GO:0099609) |
9.2 | 110.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
8.9 | 89.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
8.9 | 53.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
8.8 | 35.0 | GO:0097001 | ceramide binding(GO:0097001) |
8.3 | 107.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
7.9 | 23.7 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
7.6 | 22.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
7.5 | 22.5 | GO:0035501 | MH1 domain binding(GO:0035501) |
7.5 | 231.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
7.5 | 14.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
7.4 | 22.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
7.4 | 29.5 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
7.3 | 21.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
7.2 | 94.2 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
7.2 | 28.9 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
7.2 | 21.5 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
7.0 | 48.8 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
6.9 | 34.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
6.9 | 82.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
6.6 | 33.0 | GO:0052841 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
6.5 | 26.0 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
6.4 | 25.8 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
6.3 | 126.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
6.3 | 25.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
6.3 | 18.8 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
6.2 | 99.8 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
6.2 | 37.3 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
6.1 | 54.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
6.0 | 42.2 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
6.0 | 29.9 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
6.0 | 17.9 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
5.8 | 64.1 | GO:0008430 | selenium binding(GO:0008430) |
5.7 | 34.1 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
5.6 | 22.6 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
5.6 | 5.6 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
5.6 | 22.2 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
5.5 | 16.6 | GO:0070025 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
5.4 | 32.4 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
5.3 | 42.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
5.2 | 20.9 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
5.1 | 20.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
5.1 | 35.8 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
5.1 | 15.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
5.0 | 14.9 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
4.9 | 29.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
4.8 | 81.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
4.8 | 19.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
4.7 | 9.5 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
4.7 | 28.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
4.7 | 75.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
4.7 | 135.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
4.6 | 4.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
4.6 | 9.3 | GO:0030305 | heparanase activity(GO:0030305) |
4.6 | 13.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
4.6 | 31.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
4.5 | 36.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
4.5 | 49.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
4.4 | 13.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
4.4 | 48.1 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
4.4 | 26.1 | GO:0003998 | acylphosphatase activity(GO:0003998) |
4.3 | 17.2 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
4.3 | 17.0 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
4.2 | 33.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
4.1 | 16.4 | GO:0004803 | transposase activity(GO:0004803) |
4.1 | 8.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
4.1 | 24.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
4.0 | 11.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
4.0 | 19.8 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
4.0 | 27.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
3.9 | 55.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
3.9 | 15.7 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
3.9 | 19.5 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
3.9 | 92.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
3.8 | 15.4 | GO:0035939 | microsatellite binding(GO:0035939) |
3.8 | 22.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
3.8 | 64.2 | GO:0031005 | filamin binding(GO:0031005) |
3.8 | 30.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
3.7 | 18.7 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
3.7 | 40.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
3.6 | 3.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
3.6 | 18.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
3.6 | 14.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
3.6 | 21.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
3.6 | 17.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
3.5 | 27.8 | GO:0071253 | connexin binding(GO:0071253) |
3.5 | 10.4 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
3.4 | 13.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
3.4 | 13.7 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
3.4 | 20.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
3.4 | 34.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
3.4 | 17.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
3.4 | 20.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
3.4 | 3.4 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
3.4 | 64.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
3.3 | 13.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
3.3 | 13.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
3.3 | 9.8 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
3.2 | 19.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
3.2 | 19.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
3.2 | 12.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
3.2 | 3.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
3.2 | 60.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
3.1 | 56.4 | GO:0043274 | phospholipase binding(GO:0043274) |
3.0 | 41.6 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
2.9 | 2.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
2.9 | 8.8 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
2.9 | 40.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
2.9 | 11.6 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
2.9 | 144.0 | GO:0030507 | spectrin binding(GO:0030507) |
2.8 | 36.9 | GO:0046870 | cadmium ion binding(GO:0046870) |
2.8 | 33.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
2.8 | 36.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.8 | 22.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
2.7 | 35.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
2.7 | 21.8 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
2.7 | 13.6 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
2.7 | 54.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
2.7 | 2.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
2.7 | 8.1 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
2.7 | 18.8 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
2.7 | 18.8 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
2.7 | 26.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
2.7 | 10.7 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
2.7 | 69.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
2.7 | 21.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
2.7 | 10.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
2.7 | 8.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
2.6 | 36.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
2.6 | 57.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
2.6 | 15.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
2.6 | 20.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
2.6 | 43.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
2.6 | 7.7 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
2.6 | 12.8 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
2.5 | 53.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
2.5 | 5.0 | GO:1903135 | cupric ion binding(GO:1903135) |
2.5 | 37.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
2.5 | 32.4 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
2.4 | 7.3 | GO:0017129 | triglyceride binding(GO:0017129) |
2.4 | 34.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
2.4 | 9.7 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
2.4 | 33.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
2.4 | 7.2 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
2.4 | 4.8 | GO:0004075 | acetyl-CoA carboxylase activity(GO:0003989) biotin carboxylase activity(GO:0004075) |
2.4 | 7.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
2.4 | 9.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
2.4 | 7.2 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
2.4 | 52.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
2.3 | 84.0 | GO:0030552 | cAMP binding(GO:0030552) |
2.3 | 20.9 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
2.3 | 11.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
2.3 | 7.0 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
2.3 | 11.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
2.3 | 9.3 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
2.3 | 4.6 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
2.3 | 16.0 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
2.2 | 11.2 | GO:0000182 | rDNA binding(GO:0000182) |
2.2 | 6.7 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
2.2 | 66.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
2.2 | 8.7 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
2.2 | 6.5 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
2.2 | 6.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
2.2 | 6.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
2.2 | 10.8 | GO:0004359 | glutaminase activity(GO:0004359) |
2.1 | 10.7 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
2.1 | 4.3 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
2.1 | 8.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.1 | 10.6 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
2.1 | 33.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
2.1 | 12.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
2.1 | 12.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
2.1 | 14.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
2.1 | 6.3 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
2.1 | 6.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.1 | 10.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
2.1 | 34.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
2.0 | 6.1 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
2.0 | 14.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
2.0 | 18.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
2.0 | 52.9 | GO:0031489 | myosin V binding(GO:0031489) |
2.0 | 2.0 | GO:0070538 | oleic acid binding(GO:0070538) |
2.0 | 8.0 | GO:0017040 | ceramidase activity(GO:0017040) |
2.0 | 2.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
2.0 | 2.0 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
2.0 | 9.9 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
2.0 | 5.9 | GO:0008066 | glutamate receptor activity(GO:0008066) |
1.9 | 1.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.9 | 5.8 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.9 | 11.4 | GO:0004522 | ribonuclease A activity(GO:0004522) |
1.9 | 7.6 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.9 | 18.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.9 | 30.2 | GO:0016917 | GABA receptor activity(GO:0016917) |
1.9 | 3.8 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
1.9 | 24.5 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
1.9 | 7.5 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
1.9 | 5.6 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
1.9 | 1.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.8 | 9.2 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
1.8 | 5.5 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
1.8 | 5.5 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
1.8 | 7.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.8 | 8.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
1.8 | 17.7 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
1.8 | 14.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
1.7 | 19.2 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
1.7 | 6.8 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.7 | 15.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.7 | 25.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.7 | 3.4 | GO:0070697 | activin receptor binding(GO:0070697) |
1.7 | 3.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
1.7 | 5.0 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
1.7 | 6.7 | GO:0008940 | nitrate reductase activity(GO:0008940) |
1.7 | 15.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.7 | 8.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.7 | 5.0 | GO:0034584 | piRNA binding(GO:0034584) |
1.6 | 4.9 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
1.6 | 16.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.6 | 6.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.6 | 4.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.6 | 3.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.6 | 3.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
1.6 | 4.8 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
1.6 | 4.8 | GO:0051766 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) inositol trisphosphate kinase activity(GO:0051766) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
1.6 | 92.3 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
1.6 | 6.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.6 | 15.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.6 | 15.5 | GO:0009374 | biotin binding(GO:0009374) |
1.5 | 4.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.5 | 10.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
1.5 | 41.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.5 | 16.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.5 | 12.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.5 | 4.6 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
1.5 | 7.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.5 | 9.1 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
1.5 | 16.6 | GO:0048156 | tau protein binding(GO:0048156) |
1.5 | 4.5 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
1.5 | 5.9 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
1.5 | 10.4 | GO:0033691 | sialic acid binding(GO:0033691) |
1.5 | 29.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
1.5 | 4.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.5 | 16.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.4 | 5.8 | GO:0042731 | PH domain binding(GO:0042731) |
1.4 | 33.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.4 | 1.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.4 | 4.2 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
1.4 | 1.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.4 | 1.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
1.4 | 2.8 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
1.4 | 34.9 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.4 | 19.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.4 | 8.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
1.4 | 5.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.4 | 5.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
1.4 | 1.4 | GO:0019863 | IgE binding(GO:0019863) |
1.4 | 11.0 | GO:0034711 | inhibin binding(GO:0034711) |
1.4 | 4.1 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
1.3 | 10.8 | GO:0030172 | troponin C binding(GO:0030172) |
1.3 | 20.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.3 | 2.7 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
1.3 | 9.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.3 | 5.4 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
1.3 | 2.7 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
1.3 | 1.3 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
1.3 | 4.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.3 | 1.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
1.3 | 11.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.3 | 30.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.3 | 3.9 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
1.3 | 6.4 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
1.3 | 3.8 | GO:0070984 | SET domain binding(GO:0070984) |
1.3 | 5.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
1.3 | 5.0 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
1.3 | 5.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
1.3 | 31.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.2 | 5.0 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
1.2 | 13.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.2 | 2.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.2 | 6.2 | GO:0005499 | vitamin D binding(GO:0005499) |
1.2 | 7.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.2 | 17.3 | GO:0015250 | water channel activity(GO:0015250) |
1.2 | 2.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
1.2 | 15.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
1.2 | 20.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.2 | 3.6 | GO:0004040 | amidase activity(GO:0004040) fucose binding(GO:0042806) |
1.2 | 10.8 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
1.2 | 4.8 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.2 | 3.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.2 | 3.6 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
1.2 | 1.2 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
1.2 | 3.5 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
1.2 | 13.9 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.1 | 20.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.1 | 3.4 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
1.1 | 2.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
1.1 | 4.5 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.1 | 50.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
1.1 | 4.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.1 | 3.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
1.1 | 5.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.1 | 5.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
1.1 | 18.4 | GO:0070840 | dynein complex binding(GO:0070840) |
1.1 | 15.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
1.1 | 8.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
1.1 | 4.3 | GO:1903136 | cuprous ion binding(GO:1903136) |
1.0 | 17.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.0 | 7.3 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
1.0 | 14.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.0 | 64.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
1.0 | 50.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
1.0 | 3.1 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
1.0 | 7.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.0 | 6.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
1.0 | 7.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
1.0 | 16.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
1.0 | 2.0 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
1.0 | 1.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.0 | 4.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.0 | 3.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.0 | 5.0 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
1.0 | 4.0 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
1.0 | 14.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.0 | 4.9 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
1.0 | 4.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.0 | 23.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.0 | 4.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.0 | 3.8 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
1.0 | 11.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.0 | 4.8 | GO:0097643 | amylin receptor activity(GO:0097643) |
1.0 | 23.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.0 | 12.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.0 | 22.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.9 | 3.8 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.9 | 7.5 | GO:0099604 | intracellular ligand-gated ion channel activity(GO:0005217) calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.9 | 45.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.9 | 2.8 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.9 | 2.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.9 | 20.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.9 | 4.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.9 | 5.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.9 | 2.7 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.9 | 24.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.9 | 1.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.9 | 1.8 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.9 | 2.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.9 | 16.1 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.9 | 5.4 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.9 | 6.2 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.9 | 8.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.9 | 8.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.9 | 186.8 | GO:0015631 | tubulin binding(GO:0015631) |
0.9 | 11.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.8 | 10.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.8 | 7.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.8 | 2.5 | GO:0035473 | lipase binding(GO:0035473) |
0.8 | 3.3 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.8 | 10.7 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) BMP receptor binding(GO:0070700) |
0.8 | 19.5 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.8 | 27.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.8 | 16.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.8 | 2.4 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.8 | 19.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.8 | 8.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.8 | 2.4 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.8 | 34.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.8 | 1.6 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.8 | 15.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.8 | 6.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.8 | 5.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.8 | 10.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.8 | 2.3 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.8 | 1.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.7 | 1.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.7 | 2.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.7 | 4.5 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.7 | 27.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.7 | 26.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.7 | 6.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.7 | 2.2 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.7 | 13.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.7 | 8.7 | GO:0005112 | Notch binding(GO:0005112) |
0.7 | 1.4 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.7 | 1.4 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.7 | 20.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.7 | 2.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.7 | 0.7 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.7 | 5.6 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.7 | 4.9 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.7 | 5.5 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.7 | 4.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.7 | 2.1 | GO:0034191 | apolipoprotein receptor binding(GO:0034190) apolipoprotein A-I receptor binding(GO:0034191) |
0.7 | 49.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.7 | 2.0 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.7 | 2.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.7 | 6.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.7 | 2.6 | GO:0047708 | biotinidase activity(GO:0047708) |
0.7 | 2.0 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.7 | 2.0 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.7 | 1.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.7 | 3.9 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) phosphofructokinase activity(GO:0008443) |
0.7 | 7.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.6 | 9.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.6 | 5.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.6 | 7.0 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.6 | 0.6 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.6 | 2.5 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.6 | 7.6 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.6 | 3.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 2.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.6 | 2.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.6 | 1.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.6 | 5.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.6 | 4.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.6 | 1.8 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.6 | 4.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.6 | 10.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.6 | 2.4 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.6 | 55.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.6 | 10.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.6 | 8.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.6 | 7.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 4.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.6 | 5.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.6 | 2.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.6 | 2.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.6 | 10.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.6 | 3.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.5 | 1.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.5 | 1.6 | GO:0008431 | vitamin E binding(GO:0008431) |
0.5 | 8.9 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 11.4 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.5 | 11.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.5 | 5.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.5 | 6.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.5 | 4.1 | GO:0017022 | myosin binding(GO:0017022) |
0.5 | 2.0 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.5 | 3.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.5 | 2.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.5 | 0.5 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.5 | 2.0 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.5 | 2.5 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.5 | 2.9 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.5 | 3.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.5 | 10.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.5 | 12.1 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.5 | 149.5 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.5 | 2.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.5 | 1.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.4 | 11.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 4.9 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.4 | 2.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.4 | 1.3 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
0.4 | 1.3 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.4 | 6.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.4 | 14.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.4 | 1.2 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.4 | 9.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.4 | 2.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 2.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 4.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 2.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 0.8 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
0.4 | 1.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.4 | 2.0 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.4 | 6.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.4 | 1.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.4 | 0.8 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 5.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.4 | 1.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.4 | 1.9 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.4 | 2.7 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.4 | 1.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 50.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.4 | 0.8 | GO:0000035 | acyl binding(GO:0000035) |
0.4 | 1.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.4 | 1.1 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.4 | 4.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.4 | 40.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.4 | 3.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.4 | 0.7 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.4 | 1.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.4 | 0.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 8.1 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.4 | 3.9 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.4 | 1.8 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.3 | 0.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 1.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 4.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 3.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 8.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 4.4 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.3 | 1.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.3 | 1.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 4.3 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.3 | 95.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.3 | 1.3 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 1.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.3 | 3.2 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.3 | 1.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 73.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 0.9 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.3 | 195.2 | GO:0005509 | calcium ion binding(GO:0005509) |
0.3 | 10.8 | GO:0005262 | calcium channel activity(GO:0005262) |
0.3 | 1.8 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 1.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 3.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 1.8 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.3 | 1.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 2.6 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 2.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 2.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 1.1 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.3 | 9.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.3 | 0.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.3 | 4.3 | GO:0070330 | aromatase activity(GO:0070330) |
0.3 | 7.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.3 | 1.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 0.3 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.3 | 1.3 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.3 | 0.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.3 | 1.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 2.5 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.2 | 1.2 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.2 | 1.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 1.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 1.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 1.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 4.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 0.7 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.2 | 0.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 1.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 1.0 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.2 | 10.4 | GO:0005496 | steroid binding(GO:0005496) |
0.2 | 0.8 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.2 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 6.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 0.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 1.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 0.6 | GO:0051185 | FAD transmembrane transporter activity(GO:0015230) coenzyme transporter activity(GO:0051185) |
0.2 | 1.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 37.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 3.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.8 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 2.1 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 1.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 1.1 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 1.8 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.2 | 0.4 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 3.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 0.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.2 | 0.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 1.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 12.0 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 1.3 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 2.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.4 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 0.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 4.3 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.9 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 5.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 1.9 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 1.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.1 | 0.6 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 0.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.9 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 2.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 1.4 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.1 | 0.3 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 1.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 1.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.6 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 3.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 1.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 1.8 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.6 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 0.2 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 0.1 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.3 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.1 | 0.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.5 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.1 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.1 | 1.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 1.3 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.1 | 0.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
0.0 | 0.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.2 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.6 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 41.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
3.4 | 193.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
3.4 | 37.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
2.9 | 37.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
2.2 | 35.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
2.1 | 12.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
2.1 | 109.0 | PID RAS PATHWAY | Regulation of Ras family activation |
2.1 | 74.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.9 | 17.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.7 | 63.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
1.6 | 6.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.5 | 6.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.5 | 127.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
1.5 | 59.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.5 | 19.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
1.5 | 45.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.4 | 4.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.4 | 64.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.4 | 7.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.4 | 190.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.4 | 5.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.3 | 3.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.3 | 73.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.3 | 97.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.3 | 33.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
1.3 | 20.6 | ST GA13 PATHWAY | G alpha 13 Pathway |
1.2 | 55.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
1.1 | 66.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.1 | 30.7 | PID LKB1 PATHWAY | LKB1 signaling events |
1.1 | 14.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.0 | 26.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.0 | 32.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.0 | 9.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.9 | 41.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.9 | 23.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.9 | 51.9 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.9 | 5.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.9 | 22.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.8 | 10.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.8 | 1.7 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.8 | 20.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.8 | 9.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.8 | 0.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.7 | 16.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.7 | 2.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.7 | 19.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.7 | 3.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 16.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.6 | 13.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.6 | 6.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.6 | 15.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.5 | 4.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.5 | 11.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.5 | 9.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 11.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 20.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 5.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 5.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 4.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 15.5 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 6.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.4 | 2.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 11.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 5.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 5.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.3 | 6.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 4.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 12.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 12.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 5.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 16.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 6.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 5.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 2.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 1.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 3.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 2.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 33.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.5 | 189.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
6.9 | 125.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
5.7 | 154.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
5.2 | 162.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
5.1 | 174.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
4.9 | 117.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
4.1 | 4.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
3.9 | 78.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
3.6 | 49.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
3.4 | 106.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
3.2 | 138.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
3.0 | 74.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
2.7 | 10.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
2.7 | 8.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
2.6 | 21.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
2.6 | 121.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
2.5 | 98.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
2.3 | 64.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.3 | 25.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
2.3 | 4.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
2.2 | 145.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
2.2 | 96.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
2.2 | 83.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
2.0 | 85.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.9 | 17.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.9 | 13.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.9 | 5.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.9 | 72.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.8 | 12.9 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
1.8 | 31.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
1.7 | 29.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.7 | 8.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
1.6 | 11.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
1.6 | 39.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
1.6 | 19.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.5 | 20.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.5 | 49.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.4 | 21.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
1.4 | 18.5 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
1.4 | 148.5 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
1.3 | 11.6 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
1.3 | 42.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
1.3 | 41.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
1.2 | 12.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.2 | 18.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.2 | 15.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.2 | 28.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.1 | 3.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.1 | 13.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.1 | 16.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
1.1 | 13.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.1 | 36.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
1.1 | 6.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.1 | 1.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
1.1 | 3.2 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
1.0 | 10.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.0 | 20.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.9 | 6.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.9 | 22.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.9 | 17.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.9 | 2.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.9 | 8.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.8 | 3.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.8 | 23.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.8 | 25.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.8 | 122.4 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.8 | 17.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.8 | 11.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.8 | 12.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.8 | 23.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.7 | 3.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.7 | 3.7 | REACTOME GPCR DOWNSTREAM SIGNALING | Genes involved in GPCR downstream signaling |
0.7 | 3.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.7 | 1.5 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.7 | 64.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.7 | 23.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.7 | 0.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.7 | 24.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.7 | 3.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.7 | 19.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.7 | 63.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.6 | 88.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.6 | 32.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.6 | 1.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.6 | 2.9 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.6 | 7.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.6 | 7.8 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.6 | 6.7 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.5 | 36.8 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.5 | 20.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 9.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.5 | 4.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.5 | 2.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.5 | 11.7 | REACTOME KINESINS | Genes involved in Kinesins |
0.5 | 6.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.5 | 5.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.5 | 6.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.5 | 9.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.5 | 7.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 33.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.4 | 4.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 10.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 7.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.4 | 8.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 8.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 4.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 3.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.4 | 26.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.4 | 1.8 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.3 | 2.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 2.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.3 | 1.7 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.3 | 8.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 0.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.3 | 0.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 6.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 1.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 4.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 3.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 2.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 4.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 4.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 2.0 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.2 | 2.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 1.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 1.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 3.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 1.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 8.8 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 4.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 3.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 9.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 2.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.6 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.5 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.7 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 1.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |